<SEC-DOCUMENT>0001178913-26-003244.txt : 20260618
<SEC-HEADER>0001178913-26-003244.hdr.sgml : 20260618
<ACCEPTANCE-DATETIME>20260618070024
ACCESSION NUMBER:		0001178913-26-003244
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20260618
FILED AS OF DATE:		20260618
DATE AS OF CHANGE:		20260618

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			InMode Ltd.
		CENTRAL INDEX KEY:			0001742692
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39016
		FILM NUMBER:		261100385

	BUSINESS ADDRESS:	
		STREET 1:		TAVOR BUILDING, SHA?AR YOKNEAM
		STREET 2:		POB 533
		CITY:			YOKNEAM
		STATE:			L3
		ZIP:			2069200
		BUSINESS PHONE:		972-4-9097470

	MAIL ADDRESS:	
		STREET 1:		TAVOR BUILDING, SHA?AR YOKNEAM
		STREET 2:		POB 533
		CITY:			YOKNEAM
		STATE:			L3
		ZIP:			2069200
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2635533.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 14pt;">SECURITIES AND EXCHANGE COMMISSION</font><br>
      WASHINGTON, D.C. 20549</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 14pt;">FORM 6-K</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER<br>
      PURSUANT TO RULE 13a-16 OR 15d-16 OF<br>
      THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold;">For the month of June 2026</div>
    <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; width: 20%; color: #000000; text-align: center;"> </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 16pt;">INMODE LTD.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; width: 20%; color: #000000; text-align: center;">
      <div> <br>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;">(Exact name of registrant as specified in its charter)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Tavor Building, Sha&#8217;ar Yokneam</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;P.O. Box 533</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Yokneam 2069206&#160;Israel</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">(Address of Principal Executive Offices)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25;"> <font style="font-weight: bold;">Form 20-F &#9746;&#160;&#160;&#160;&#160;&#160; Form 40-F &#9744;</font></div>
    <div><font style="font-weight: bold;"> </font><br>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
        Securities Exchange Act of 1934:</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;"> <font style="font-weight: bold;">Yes <font style="font-weight: bold;">&#9744;<font style="font-weight: bold;">&#160;&#160;&#160;&#160;&#160; </font></font>No &#9746;</font></div>
      <div><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
      <div style="text-align: justify; line-height: 1.25;">On June 18, 2026, InMode Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) announced that it will hold its Annual General Meeting of the Shareholders of the Company on Thursday, July 30,
        2026, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha&#8217;ar Yokneam Industrial Park, Yokneam, Israel. A copy of the proxy statement is attached hereto as Exhibit 99.1.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z0dafe09e00b2456cacf4dd236547fe5f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;"><u>Exhibit No.</u></div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;"><u>Description of Exhibit</u></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 90%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">Proxy Statement dated June 18, 2026</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
        authorized.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5b512703d8924176b5c6d56a1ba51122" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">InMode Ltd.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">By: <u>/s/ Moshe Mizrahy</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">Moshe Mizrahy</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">Dated June 18, 2026</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25; text-align: right;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;"><img width="362" height="149" src="image0.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel</div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: right; line-height: 1.25;">June 18, 2026</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Dear Shareholder,</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You are cordially invited to attend the annual general meeting (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;) of the shareholders of InMode Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), to be held on Thursday, July 30, 2026, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha&#8217;ar Yokneam Industrial Park, Yokneam, Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company&#8217;s notice of the Meeting, as published on June 18, 2026, and the proxy statement (&#8220;<font style="font-weight: bold;">Proxy Statement</font>&#8221;) included within the
      following pages, describe in detail the matters to be acted upon at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Only shareholders who held shares at the close of business on June 26, 2026, are entitled to notice of, and to vote at, the Meeting and any adjournment or postponement thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">The Company&#8217;s board of directors recommends a vote &#8220;FOR&#8221; each of the matters set forth in the notice.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">Whether or not you plan to attend the Meeting, it is important that your shares be represented and voted at the Meeting. Shareholders are urged to complete and
      return their proxies promptly in order to, among other things, ensure action by a quorum and to avoid the expense of additional solicitation. Accordingly, after reading the enclosed Notice of Annual General Meeting of Shareholders and accompanying
      Proxy Statement, please sign, date, and mail the enclosed proxy card by means of the envelope provided, or otherwise vote by telephone or over the internet in accordance with the instructions given in your proxy card.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We look forward to seeing as many of you as can attend the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zba7f1a30afe440c5bc8cc835cd3b536d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">BY ORDER OF THE BOARD OF DIRECTORS</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Shlomo Nass</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Dr. Shlomo Nass</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Chairman of the Board</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INMODE LTD.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25;">Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel<br>
        Tel: +972-4-909-6313</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">To be held on July 30, 2026</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Notice is hereby given to the holders of ordinary shares, par value NIS 0.01 per share, of&#160;InMode Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) in connection with
      the solicitation by the board of directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) of proxies for use at the annual general meeting of its shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;) to be held
      on&#160;Thursday, July 30, 2026, at 17:00 Israel time, at the offices of the Company at Tavor Building, Sha'ar Yokneam Industrial Park, Yokneam, Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Meeting is being called for the following purposes:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To re-elect Dr. Hadar Ron, to the Company&#8217;s Board, to serve as a Class I director of the Company, and to hold office until the close of business on the date of the
      Company&#8217;s annual general meeting of shareholders to be held in 2029 and until her successor is duly elected and qualified, or until her earlier resignation or retirement;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To approve the re-appointment of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member of PricewaterhouseCoopers International Limited<font style="font-weight: bold;">&#160;</font>(&#8220;<font style="font-weight: bold;">PwC</font>&#8221;), our independent registered public accounting firm, as the Company&#8217;s independent auditors for the fiscal year ending December 31, 2026, and its service until the
      annual general meeting of shareholders to be held in 2027;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To approve the grant of a total of 6,000 restricted share units (&#8220;<font style="font-weight: bold;">RSUs</font>&#8221;) under the Company&#8217;s 2018 Incentive Plan to the
      following non-executive directors: Dr. Shlomo Nass (2,000 RSUs), Dr. Hadar Ron (2,000 RSUs) and Mr. Nadav Kenneth (2,000 RSUs), half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15, 2028, subject to
      their continued service on the dates of vesting; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To approve the compensation terms of the Special Committee of the Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">The Board recommends that the shareholders vote in favor of each of the above proposals, which will be described in a proxy statement to be
      made available to the Company&#8217;s shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, shareholders attending the Meeting will have an opportunity to review and ask questions regarding the financial statements of the Company for the fiscal year ended
      December 31, 2025.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are currently not aware of any other matters that will come before the Meeting. If any other matters are presented properly at the Meeting,&#160;it is intended that&#160;the persons
      designated as proxies will vote upon such matters in accordance with their best judgment&#160;and the interest of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Israeli Companies Law 5759-1999 (the &#8220;<font style="font-weight: bold;">Companies Law</font>&#8221;), and regulations promulgated thereunder, one or more
      shareholders of the Company holding at least 1% (one percent) of the outstanding voting rights of the Company for the Meeting may submit to the Company a proposed additional agenda item for the Meeting. However, pursuant to Israeli Companies
      Regulations (Reliefs for Companies with Securities Listed on an Exchange Outside of Israel), 5760-2000 (&#8220;<font style="font-weight: bold;">Relief Rules</font>&#8221;), a shareholder proposed additional agenda item related to: (i) the election of a new
      nominee to our Board , or (ii) the removal of a currently serving member of our Board, may only be submitted by one or more shareholders holding at least 5% of the voting power of our outstanding ordinary shares. Any such request must comply with the
      requirements of the Companies Law and regulations promulgated thereunder and the applicable provisions in the Company&#8217;s articles of association, and should be sent to Mr. Moshe (Moshik) Itzkovich, our CFO, either via mail to the Company&#8217;s offices at
      Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel, Attention: Moshik Itzkovich, CFO, or by e-mail to <u>Moshik.Itzkovich@InModemd.com</u>. For a shareholder proposal to be considered for inclusion at the Meeting, our CFO must
      receive the written proposal, together with all the accompanying documentation and information duly completed and signed as required to be submitted under the Companies Law and regulations promulgated thereunder and the applicable provisions in the
      Company&#8217;s articles of association, no later than June 25, 2026. The Company shall be entitled to publish information provided by a proposing shareholder, and the proposing shareholder shall be responsible for the accuracy thereof. The Company may
      disregard shareholder proposals that are not timely and validly submitted. To the extent that the Board determines that a shareholder proposal is duly and timely received and is appropriate under the Companies Law for inclusion in the agenda of the
      Meeting, the Company will publish an updated agenda and proxy card with respect to the Meeting, no later than July 2, 2026, by way of issuing a press release or submitting a Current Report on Form 6-K to the SEC. However, the record date for the
      meeting will not change as a result.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%2%- % -%-->
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The presence (in person or by proxy) of any two or more shareholders holding, in aggregate, at least 25% of the voting rights in the Company, constitutes a quorum for purposes of
      the Meeting. In the absence of the requisite quorum of shareholders at the Meeting, the Meeting will be adjourned to Thursday, August 6, 2026, at the same time and place, unless otherwise determined at the Meeting in accordance with the Company&#8217;s
      articles of association (the &#8220;<font style="font-weight: bold;">Adjourned Meeting</font>&#8221;). At such Adjourned Meeting the presence of any shareholder in person or by proxy (regardless of the voting power represented by their shares) will constitute a
      quorum.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Only shareholders of record at the close of business on Friday, June 26, 2026, are entitled to notice of, and to vote at, the Meeting, or at any adjournment or postponement
      thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Approval of each of Proposals 1, 2, 3 and 4 requires the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting or at any adjournment
      thereof in person or by proxy and voting thereon.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">In addition, under Israeli law, approval of Proposal 4 requires that at least one of the following two alternative voting requirements be met as part of the approval by the
      aforesaid majority of the ordinary shares present and voting thereon:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0a2b08cad5f0498c90e60c496f3ba380" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 14.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>approval by a majority of the ordinary shares held and voted at the Meeting by non-controlling shareholders who do not have a personal interest in the approval of the applicable proposal, excluding abstentions; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z77cc4e07a5a24e299e0528258e048bdf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 14.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the total number of shares held by non-controlling, disinterested shareholders (as described in the previous bullet-point) and voted against the applicable proposal, does not exceed two percent (2%) of the aggregate voting rights in the
              Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Please see the discussion under &#8220;Quorum and Required Vote&#8221; in the proxy statement attached to this notice for the definition of the terms &#8220;controlling shareholder&#8221; and
      shareholder having &#8220;personal interest&#8221; with regard to Proposal 4, as well as for instructions as to how to vote in the event that you possess a personal interest in the approval of Proposal 4.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A proxy statement describing the various matters to be voted upon at the Meeting along with a proxy card enabling the shareholders&#160;to&#160;indicate their vote on each matter will be
      mailed to all shareholders entitled to participate in and vote at the Meeting. Such proxy statement will also be&#160;publicly filed with&#160;the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;) under cover of Form
      6-K and will be available on the&#160;Company&#8217;s&#160;website&#160;<u>www.inmodemd.com</u>. Proxies must be submitted to the Company no later than 11:59pm (Israel time) on the night prior to the Meeting or to its transfer agent, Equiniti Trust Company, LLC, no later
      than 5:00pm ET on the day prior to the Meeting.&#160;Proxies delivered to the Company or to its transfer agent after such time will be presented to the chairperson of the Meeting and, at his discretion, may be voted as specified in the instructions
      included in such proxies. If your ordinary shares in the Company are held in &#8220;street name&#8221; (meaning held through a bank, broker or other nominee), you will be able to either direct the record holder of your shares on how to vote your shares or obtain
      a legal proxy from the record holder that enables you to participate in and to vote your shares at the Meeting (or to appoint a proxy to do so).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">BY ORDER OF THE BOARD OF DIRECTORS</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Shlomo Nass</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Dr. Shlomo Nass</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Chairman of the Board</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;">June 18, 2026</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- ii -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">INMODE LTD.</font><br>
      Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel<br>
      Tel: +972-4-909-6313</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROXY STATEMENT</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">General Information</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This proxy statement (the &#8220;<font style="font-weight: bold;">Proxy Statement</font>&#8221;) and the accompanying proxy card are being furnished to the holders of ordinary shares, par
      value NIS 0.01 per share, of InMode Ltd., an Israeli company (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), in connection with the solicitation of proxies by the board of directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;),



      for use at the annual general meeting of shareholders of the Company (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;) to be held on&#160;Thursday, July 30, 2026, beginning at 17:00 Israel time, at the offices of the Company at Tavor Building,
      Sha&#8217;ar Yokneam Industrial Park, Yokneam, Israel.&#160;You are entitled to notice of, and to vote at, the Meeting, if you hold ordinary shares as of the close of business on&#160;Friday, June 26, 2026, the record date for the Meeting (the &#8220;<font style="font-weight: bold;">Record Date</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">The Proxy</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each of Mr. Moshe Mizrahy (CEO) and Mr. Moshik Itzkovich (CFO) may be appointed as proxies by the shareholders entitled to vote at the Meeting with respect to the matters to be
      voted upon at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All ordinary shares represented by properly executed proxies delivered to the Company&#8217;s transfer agent, Equiniti Trust Company, LLC, or to the Company by mail at its offices at
      Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel, Attention: Moshik Itzkovich, CFO, or by e-mail to <u>Moshik.Itzkovich@InModemd.com</u>, will be voted as specified in the instructions indicated in such proxies. Proxies must be
      submitted to the Company no later than 11:59pm (Israel time) on the night prior to the Meeting or to its transfer agent, Equiniti Trust Company, LLC, no later than 5:00pm ET on the day prior to the Meeting. Proxies delivered to the Company or to its
      transfer agent after such time will be presented to the chairperson of the Meeting and, at his discretion, may be voted as specified in the instructions included in such proxies.&#160;If you are a shareholder of record as of the record date for the
      Meeting, subject to applicable law and the rules of the Nasdaq Global Select Market (&#8220;<font style="font-weight: bold;">Nasdaq</font>&#8221;), if no instructions are indicated in such proxies with respect to the Proposals, the shares represented by properly
      executed and received&#160;proxies will be voted &#8220;FOR&#8221; each of the Proposals. If you hold your shares in &#8220;street name&#8221; through a broker, bank or other nominee, you are considered, with respect to those shares, a beneficial owner.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Revocation of Proxies</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A shareholder may revoke a proxy in one of the following ways: (i) by written notice of the revocation of the proxy delivered to the Company&#8217;s transfer agent, Equiniti Trust
      Company, LLC no later than 5:00pm ET on the day prior to the Meeting, or by mail to the Company at its offices<font style="font-weight: bold;">&#160;</font>at Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel, Attention: Moshik
      Itzkovich, CFO, or by e-mail to <u>Moshik.Itzkovich@InModemd.com</u>, before 11:59pm (Israel time) on the night prior to the time of the Meeting canceling the proxy or appointing a different proxy, (ii) by written notice of the revocation of the
      proxy delivered at the Meeting to the chairperson of the Meeting, or (iii) by&#160;attending&#160;and voting in person at the Meeting. Attendance at the Meeting will not in and of itself constitute revocation of a proxy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Shareholders Entitled to Vote &#8211; Record Date</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Shareholders of record who held ordinary shares at the close of business on Friday, June 26, 2026, are entitled to notice of, and to vote at, the Meeting. In addition, shareholders
      who, as of the Record Date, held ordinary shares through a bank, broker or other nominee which is a shareholder of record of the Company at the close of business on the Record Date, or which appears in the participant list of a securities depository
      on that date, are considered to be beneficial owners of shares held in &#8220;street name&#8221;. These proxy materials are being forwarded to beneficial owners by the bank, broker or other nominee that is considered the holder of record with respect to the
      Company&#8217;s ordinary shares. Beneficial owners have the right to direct how their shares should be voted and are also invited to attend the Meeting but may not actually vote their shares in person at the Meeting unless they first obtain a signed proxy
      from the record holder (that is, their bank, broker or other nominee) giving them the right to vote the shares.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of May 31, 2026, there were 57,480,772 ordinary&#160;shares&#160;issued, outstanding and entitled to vote at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Quorum and Required Vote</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Company&#8217;s articles of association, the quorum required for the Meeting consists of at least two shareholders present, in person or by proxy, who hold or represent
      between them at least 25% of the Company&#8217;s voting power. If a quorum is not present within thirty (30) minutes from the time designated for the Meeting, the Meeting will stand adjourned to Thursday, August 6, 2026,&#160;at the same time and place, unless
      otherwise determined at the Meeting in accordance with the Company&#8217;s articles of association&#160;(the &#8220;<font style="font-weight: bold;">Adjourned Meeting</font>&#8221;).&#160;At such Adjourned Meeting the presence of any shareholder in person or by proxy
      (regardless of the voting power represented by their shares) will constitute a quorum. Any reference in this Proxy Statement to the term Meeting shall include the term &#8220;Adjourned Meeting&#8221; for all purposes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Abstentions and &#8220;broker non-votes&#8221; are counted as present and entitled to vote for purposes of determining a quorum. A &#8220;broker non-vote&#8221; occurs when a bank, broker or other holder
      of record holding shares for a beneficial owner attends the Meeting but<font style="font-weight: bold;">&#160;</font>does not vote on a particular proposal because that holder does not have discretionary voting power for that particular item and has not
      received instructions from the beneficial owner. Brokers that hold shares in &#8220;street name&#8221; for clients typically have authority to vote on &#8220;routine&#8221; proposals even when they have not received instructions from beneficial owners. Absent specific
      instructions from the beneficial owner of the shares, however, brokers are not allowed to exercise their voting discretion with respect to any proposals that are considered non-routine. If you hold your shares in &#8220;street name&#8221; and do not provide your
      broker with specific instructions regarding how to vote on any proposal, your broker will not be permitted to vote your shares on the proposals, resulting in a &#8220;broker non-vote&#8221;. Therefore,&#160;it is important for a shareholder that holds&#160;ordinary&#160;shares
      through a bank or broker to instruct its&#160;bank&#160;or&#160;broker&#160;how to vote its shares, if the shareholder wants its shares to count for all proposals.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Approval of each of Proposals 1, 2, 3 and 4 requires the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting or at any adjournment
      thereof in person or by proxy and voting thereon.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">In addition, under Israeli law, approval of&#160;Proposal 4 requires that at least one of the following two alternative voting requirements be met as part of the approval by the
      aforesaid majority of the ordinary shares present and voting thereon:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4759673a16404be5bd63aa524285b07a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 14.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>approval by a majority of the ordinary shares held and voted at the Meeting by non-controlling shareholders who do not have a personal interest in the approval of the applicable proposal, excluding abstentions; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3a9387c0a3d6473b9b4b7957aadc5c92" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 14.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the total number of shares held by non-controlling, disinterested shareholders (as described in the previous bullet-point) and voted against the applicable proposal, does not exceed two percent (2%) of the aggregate voting rights in the
              Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">For purposes of Proposal 4, a &#8220;<font style="font-weight: bold;">controlling shareholder</font>&#8221; is any shareholder that has the ability to direct the Company's activities (other
      than by means of being a director or other office holder of the Company). A person is presumed to be a controlling shareholder (a) if it holds or controls, by itself or together with others, 50% or more of any one of the &#8220;means of control&#8221; of the
      Company, or (b) only with respect to Proposal 4, if it holds or controls, by itself or together with others who also possess a personal interest in the approval of the same transaction, 25% or more of the voting rights in the Company, if no other
      shareholder holds or controls more than 50% of the voting rights in the Company. &#8220;<font style="font-weight: bold;">Means of control</font>&#8221; is defined under Israeli law as any one of the following: (i) the right to vote at a general meeting of the
      Company, or (ii) the right to appoint directors of the Company or its chief executive officer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">We are unaware of any shareholders that would be deemed to be a controlling shareholder of the Company as of the current time for purposes of Proposal 4 above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">A &#8220;<font style="font-weight: bold;">personal interest</font>&#8221; of a shareholder includes a personal interest of a shareholder in an action or a transaction of the Company,
      excluding any interest arising solely from holding our shares, but including the personal interest of the shareholder&#8217;s spouse, siblings, parents, grandparents, descendants, spouse&#8217;s descendants, siblings or parents or the spouse of any of such
      persons, and the personal interest of any entity in which the shareholder or one of the aforementioned relatives of the shareholder serves as a director or chief executive officer, owns 5% or more of such entity&#8217;s outstanding shares or voting rights
      or has the right to appoint one or more directors or the chief executive officer. Under the Companies Law, in the case of a person voting by proxy, &#8220;personal interest&#8221; includes the personal interest of either the proxy holder or the shareholder
      granting the proxy, whether or not the proxy holder has discretion over how to vote.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">A controlling shareholder and a shareholder that has a personal interest are qualified to participate in the vote on the proposals;&#160;however, with respect to Proposal 4, the vote
      of such shareholders may not be counted towards the majority requirement described in the first bullet-point above nor be counted towards the 2% threshold described in the second bullet-point above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25; font-weight: bold;">In accordance with the Israeli Companies Regulations (Reliefs for Companies with Securities Listed on an Exchange Outside of Israel), 5760-2000, a shareholder
      submitting a vote for proposal 4 is deemed to confirm to the Company that such shareholder DOES NOT HAVE a personal interest in such proposal and is NOT a controlling shareholder, unless such shareholder had delivered to the Company a notice in
      writing stating otherwise, no later than 11:59pm (Israel time) on the night prior to the Meeting, to the attention of the Company&#8217;s Chief Financial&#160; Officer, Mr.&#160;Moshik Itzkovich, at Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206,
      Israel, or via&#160;e-mail: Moshik.Itzkovich@InModemd.com. If you hold your shares in a &#8220;street name&#8221; (i.e., shares that are held through a bank, broker or other nominee) and believe that you are a controlling shareholder or possess a personal interest in
      the approval of Proposal&#160;4 above, you may also contact the representative managing your account, who could then contact our Chief Financial Officer on your behalf, as described in the preceding sentence.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board recommends shareholders vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; each of the Proposals set forth in the Proxy Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Except for the purpose of determining a quorum, broker non-votes will not be counted as present and are not entitled to vote. Abstentions will be counted as present, but will not
      be treated as either a vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; a matter and, accordingly, will be deemed to be not voted on the matter.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On each matter submitted to the shareholders for consideration at the Meeting, only ordinary shares that are voted on such matter will be counted toward determining whether
      shareholders approved the matter. Ordinary shares present at the Meeting that are not voted on a particular matter (including broker non-votes and abstentions) will not be counted in determining whether such a matter is approved by shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each ordinary share is entitled to one vote on each proposal or item that comes before the Meeting. If two or more persons are registered as joint owners of any ordinary share, the
      right to vote at the Meeting and/or the right to be counted as part of the quorum thereat will be conferred exclusively upon the more senior among the joint owners attending the Meeting in person or by proxy. For this purpose, seniority will be
      determined by the order in which the names appear in the Company&#8217;s Register of Shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">How You Can Vote</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You can vote your shares by attending the Meeting. If you do not plan to attend the Meeting, the method of voting will differ for shares held as a record holder and shares held in
      &#8220;street name&#8221; (through a broker, trustee or nominee). Record holders of shares will receive proxy cards. Holders of shares in &#8220;street name&#8221; will receive either proxy cards or voting instruction cards directly from their bank, broker or nominee in
      order to instruct their banks, brokers or other nominees on how to vote.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Shareholders of Record</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If you are a shareholder of record (that is, you hold a share certificate that is registered in your name or you are listed as a shareholder in the Company&#8217;s share register), you
      can submit your vote by completing, signing and submitting a proxy card, which has or will be sent to you and which will be accessible at the Investors section of the Company&#8217;s website, as described below under &#8220;Availability of Proxy Materials.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Please follow the instructions on the proxy card. If you provide specific instructions (by marking a box) with regard to the proposals, your shares will be voted as you instruct.
      The persons named as proxies in the enclosed proxy card will furthermore vote in accordance with the recommendations of the Board on any other matters that may properly come before the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Shareholders Holding in &#8220;Street Name&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If you hold the Company&#8217;s ordinary shares in &#8220;street name,&#8221; that is, you are an underlying beneficial holder who holds ordinary shares through a bank, broker or other nominee, the
      voting process will be based on your directing the bank, broker or other nominee to vote the ordinary shares in accordance with the voting instructions on your voting instruction card. Because a beneficial owner is not a shareholder of record, you
      may not vote those shares directly at the Meeting unless you obtain a &#8220;legal proxy&#8221; from the bank, broker or nominee that holds your shares, giving you the right to vote the shares at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Please follow the instructions on the voting instruction card received from your bank, broker or nominee. You may also be able to submit voting instructions to a bank, broker or
      nominee by phone or via the Internet if your voting instruction card describes such voting methods. Please be certain to have your control number from your voting instruction card ready for use in providing your voting instructions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is important for a shareholder that holds ordinary shares through a bank or broker to instruct its bank or broker how to vote its shares if the shareholder wants its shares to
      count for the proposal.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Voting Results</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The final voting results will be tallied by the Company&#8217;s legal counsel, based on the information provided by the Company&#8217;s transfer agent or otherwise and will be published
      following the Meeting on a Form 6-K that will be publicly filed with the SEC.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Proxy Solicitation</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company will bear the costs of solicitation of proxies for the Meeting. In addition to solicitation by mail, directors, officers, employees and agents of the Company may
      solicit proxies from shareholders by telephone, email, personal interview or otherwise. Such directors, officers, employees and agents will not receive additional compensation but may be reimbursed for reasonable out-of-pocket expenses in connection
      with such solicitation. Brokers, nominees, fiduciaries and other custodians have been requested to forward soliciting material to the beneficial owners of ordinary shares held of record by them, and such custodians will be reimbursed by the Company
      for their reasonable out-of-pocket expenses. The Company may also retain independent contractor to assist in the solicitation of proxies. If retained for such services, the costs will be paid by the Company. Proxies must be submitted to the Company
      no later than 11:59pm (Israel time) on the night prior to the Meeting or to its transfer agent, Equiniti Trust Company, LLC, no later than 5:00pm ET on the day prior to the Meeting. Proxies delivered to the Company or to its transfer agent after such
      time will be presented to the chairperson of the Meeting and, at his discretion, may be voted as specified in the instructions included in such proxies.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Availability of Proxy Materials</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Copies of the proxy card, the Notice of the Annual Meeting of Shareholders and this Proxy Statement are available in the Investors section of our Company&#8217;s website at&#160;<u>www.inmodemd.com</u>.
      The contents of that website are not a part of this Proxy Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For information regarding compensation granted to the Company&#8217;s executive officers during or with respect to the year ended December 31, 2025, please see Item 6B. of our Annual
      Report on Form 20-F for the year ended December 31, 2025, which was filed with the SEC on February 10, 2026, and is accessible through the Company&#8217;s website at&#160;<u>www.inmodemd.com</u>&#160;or through the SEC&#8217;s website at&#160;<u>www.sec.gov</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">BENEFICIAL OWNERSHIP OF SECURITIES BY CERTAIN</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">BENEFICIAL OWNERS AND MANAGEMENT</div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table sets forth certain information regarding the beneficial ownership of the Company&#8217;s ordinary shares as of May 31, 2026, by:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7d7b1f68d4494c368406db0467750a99" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>each of the Company&#8217;s directors and executive officers;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb5c6168deeb4446985ce88ead48fdbed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>all of the Company&#8217;s executive officers and directors collectively as a group; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7c843bd77cb04d2a82b75decffbb7c95" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>each person (or group of affiliated persons) known by the Company to be the beneficial owner of more than 5% of the outstanding ordinary shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The beneficial ownership of the Company&#8217;s ordinary shares is determined in accordance with the rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a
      security if that person has or shares voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes the power to dispose of or to direct the disposition of the security. For purposes of
      the table below, we deem ordinary shares issuable pursuant to options, RSUs or warrants that are currently exercisable or will become exercisable within 60 days as of May 31, 2026, if any, to be outstanding and to be beneficially owned by the person
      holding the options, RSUs or warrants for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. The percentage of ordinary
      shares beneficially owned is based on 57,480,772 ordinary shares outstanding (excluding treasury shares) as of May 31, 2026, according to our transfer agent, and 30,000 ordinary shares exercisable within 60 days of May 31, 2026, owned by the above
      beneficial owners.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Except where otherwise indicated, we believe, based on information furnished to us by such owners and based on public information, that the beneficial owners of the ordinary shares
      listed below have sole investment and voting power with respect to such shares. In addition, none of the Company&#8217;s shareholders have different voting rights from other shareholders. To the best of our knowledge, we are not controlled, directly or
      indirectly, by another corporation or by any foreign government. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unless otherwise noted below, the address of each shareholder, director and executive officer listed in the table is c/o InMode Ltd., Tavor Building, Sha&#8217;ar Yokneam, P.O. Box
        533, Yokneam 2069206, Israel.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z0f9427cb1f6145fc9b3bf80224fa8602" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">Name of Beneficial Owner:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number of Ordinary Shares</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Percentage of Ordinary Shares</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25; font-weight: bold;">Directors and Executive Officers</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Dr. Shlomo Nass</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Moshe Mizrahy</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,299,226</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">7.48</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Dr. Michael Kreindel</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,114,762</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">5.42</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Dr. Hadar Ron</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">57,270</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Nadav Kenneth</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,500</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Moshik Itzkovich<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">7,503</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Michael Dennison</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">7,654</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 76%;">
            <div style="margin-left: 9pt">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="line-height: 1.25; margin-left: 9pt;">Yair Malca<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">124,192</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" rowspan="1" style="vertical-align: top; background-color: rgb(204, 238, 255); width: 76%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" rowspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" rowspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" rowspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" rowspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" rowspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" rowspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="line-height: 1.25; font-weight: bold;">Total for all Directors and&#160;Executive Officers as&#160;a Group (7 persons)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">7,487,915</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">13.03</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">%</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2fbc15101a164c3fa4d4ba27c7565e3f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">*</td>
          <td style="width: auto; vertical-align: top;">
            <div>Represents beneficial ownership of less than one (1%) percent.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z98e302bfd47342429918d503cadba50d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Mr. Moshik Itzkovich's beneficial ownership includes a total of 1,073 shares owned by his wife, Ms. Nofar Ekhoiz, who is employed by the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf01b1d82d2904d6783817916fa73bb55" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Mr. Yair Malca&#8217;s beneficial ownership consists of: (i) 94,192 ordinary shares, and (ii) options to purchase 30,000 ordinary shares, exercisable within 60 days of May 31, 2026, with an exercise price of $9.845, with such options expiring on
              March 14, 2027.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25;">Mr. Malca resigned as our Chief Financial Officer, effective May 5, 2026. He is included in this table because he is a named executive officer for the fiscal year ended December
      31, 2025, but he is not counted for purposes of aggregating beneficial ownership of our current executive officers and directors as a group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">BACKGROUND FOR ELECTION OF DIRECTORS</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Company&#8217;s articles of association, the number of directors on the Company&#8217;s Board is fixed by the Board provided it is not less than three (3) and not more than seven (7)
      members. Currently, there are five (5) directors serving on the Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our directors are divided into three classes set forth in the Company&#8217;s articles of association, as follows:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z70a2fd96f3974bb49ff479556a59c528" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Class I director is Dr. Hadar Ron, and her term will expire at the Meeting and when her successor is elected and qualified;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z742c6c6683a44572be0e1a90615057cc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Class II directors are Dr. Shlomo Nass and Mr. Nadav Kenneth, and their terms will expire at the annual general meeting of the shareholders to be held in 2027 and when their successors are elected and qualified; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9bebf5e61df840c4bc216f3b10fe8918" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Class III directors are Mr. Moshe Mizrahy and Dr. Michael Kreindel, and their terms will expire at the annual general meeting of the shareholders to be held in 2028 and when their successors are elected and qualified.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to our articles of association, the term of office of the Class I director, Dr. Hadar Ron, expires at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, the shareholders will be asked to re-elect Dr. Hadar Ron as Class I director, following her nomination by our Compensation, Nominating and Corporate Governance
      Committee and our Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the corporate governance standards promulgated by Nasdaq, a majority of our directors must meet certain independence requirements. Following the Meeting, assuming the
      re-election of the Board nominee, our Board will consist of five (5) members, three (3) of whom will be independent under the Nasdaq rules. Specifically, our Board determined that Dr. Shlomo Nass, Dr. Hadar Ron and Mr. Nadav Kenneth, meet the
      independence standards and committee qualifications under the Nasdaq rules and that Dr. Shlomo Nass is qualified to serve as an &#8220;audit committee financial expert&#8221; as defined by SEC and Nasdaq rules. In reaching this conclusion, the Board evaluated
      the relationship between the Company and each of these directors and director nominees and determined that none of these directors and director nominees has a relationship that would preclude a finding of independence and any relationships that these
      directors and director nominees have with the Company do not impair their independence.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As a foreign private issuer, we are permitted under Nasdaq rules to follow Israeli law and practice in lieu of certain Nasdaq corporate governance requirements, including those
      relating to the process of nominating directors. Consistent with our commitment to strong corporate governance, our director nominations are made by our Compensation, Nominating and Corporate Governance Committee, which is composed of independent
      directors and recommends nominees to the Board and, in turn, to our shareholders in accordance with Israeli law and practice. Except for the home-country practices described in Item 16G of our Annual Report on Form 20-F, the Company otherwise
      voluntarily observes the corporate governance standards applicable under the Nasdaq rules.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Company&#8217;s articles of association, the directors who are serving in office will be entitled to act even if a vacancy occurs on the Board. However, should the number of
      directors, at the time in question, become&#160;less&#160;than the minimum set forth in our articles of association, the remaining director(s) will be entitled to act for the purpose of filling the vacancies which will have occurred on the Board or for
      convening a general meeting, but not for any other purpose.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL ONE<br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> RE-ELECTION OF CLASS I DIRECTOR</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Background</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Board and Compensation, Nominating and Corporate Governance Committee have nominated the currently serving Class I director, Dr. Hadar Ron, for re-election, and our
      shareholders are being asked to re-elect at the Meeting, Dr. Hadar Ron, to serve as a Class I director of the Company, for a term commencing on the date of the Meeting until the Company&#8217;s annual general meeting of shareholders to be held in 2029. If
      re-elected, and as approved by our Board, Dr. Ron is expected to continue serving as the chairperson of our Compensation, Nominating and Corporate Governance Committee and as a member of our Audit &amp; Investment Committee (the &#8220;<font style="font-weight: bold;">Audit Committee</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Dr. Hadar Ron has consented to being named in this Proxy Statement and has informed us that she is willing to serve as a director if elected.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Companies Law, Dr. Hadar Ron has certified to us that she satisfies all of the requirements of the Companies Law to serve as a director of a public company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If re-elected pursuant to this proposal, Dr. Hadar Ron will continue to be party to an indemnification and exculpation agreement with the Company in the form of indemnification
      letter and exculpation letter which was entered into in connection with our initial public offering and listing on Nasdaq. Dr. Hadar Ron will also continue to be insured under the Company&#8217;s directors&#8217; and officers&#8217; insurance coverage policy in effect
      from time to time, which provides coverage for all directors and other officers of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, if re-elected pursuant to this proposal, Dr. Hadar Ron will continue to receive cash participation compensation and annual compensation in accordance with the Relief
      Rules, with reference to the Israeli Companies Law Regulations (Rules concerning Compensation and Expenses of an External Director), 5760-2000, and in accordance with our Amended and Restated Compensation Policy (the &#8220;<font style="font-weight: bold;">Compensation



        Policy</font>&#8221;).&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Set forth below is information about the nominee, Dr. Hadar Ron, including age, positions held, principal occupation, business history and experience as director, based upon
      records of the Company and information provided to us by the nominee:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Dr. Hadar Ron, M.D. L.L.B.</font>&#160;<font style="font-style: italic;">(Age 67)</font>. Dr. Hadar Ron became a director of the
      Company in August 2019. Since 2000, Dr. Ron has been the founding and managing partner of Israel Healthcare Ventures, an Israeli life science venture capital fund. Dr. Ron is also the chief executive officer of the management company for Israel
      Healthcare Ventures 2 LP Incorporated, an Israeli life sciences venture capital fund. Dr. Ron currently serves as chairperson of G.I. View Ltd., a medical device company specializing in colorectal screenings, and Neurohelp Ltd., a Neurotechnology
      start-up company, and as a board member of the following companies: Pet Novations Ltd., Peri-Ness Technologies Ltd., O.G.D.H. Ltd., OrSense Ltd., and Unbox Ventures Ltd. In addition, Dr. Ron currently serves as an external director of Together Pharma
      Ltd. (TASE:TGTR), a bio-med company operating in the field medical cannabis. In addition, Dr. Ron serves as a member of the advisory board of the Momentum Fund Tech Transfer of Tel Aviv University, a board member of BIRAD Ltd., the tech transfer
      company of Bar Ilan University. Dr. Ron is a physician and attorney by education. She holds M.D. and L.L.B. degrees from Tel Aviv University and has studied at the School of Business Administration at Tel Aviv University.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Proposed&#160;Resolutions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are therefore proposing to adopt the following resolutions:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>,&#160;to re-elect Dr. Hadar Ron to serve as a Class I director of the Company, and to hold office until the annual general meeting of
      shareholders to be held in 2029&#160;and until her successor is duly elected and qualified, or until her earlier resignation or retirement.&#8221;</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">See &#8220;Quorum and Required Vote&#8221; above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25; font-weight: bold;">The Board unanimously recommends that you vote &#8220;FOR&#8221; the proposed resolutions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">As the above nominee for re-election has a personal interest in the foregoing proposed resolution regarding her re-election, the nominee has refrained from
      making a recommendation with respect to her own re-election.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL TWO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RE-APPOINTMENT OF AUDITORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Background</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member of PricewaterhouseCoopers International Limited, (&#8220;<font style="font-weight: bold;">PwC</font>&#8221;), our
      independent registered public accounting firm, audited our financial statements for the year ended December 31, 2025. PwC has served as our auditors since our inception in 2008. PwC does not have and has not had any financial interest, direct or
      indirect, in our Company, and does not have and has not had any connection with our Company except in its professional capacity as our independent auditors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Audit Committee and Board have authorized and approved the appointment of PwC as the Company&#8217;s independent registered public accounting firm for the year ending December 31,
      2026, and until the next annual general meeting. Our Audit Committee and Board believe that the appointment of PwC as the independent public accountants of the Company is appropriate and in the best interest of the Company and its shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;Under the Companies Law and our articles of association, the shareholders of the Company are authorized to appoint the Company&#8217;s independent auditors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Audit Committee, in accordance with our charter, reviews and pre-approves all audit services and permitted non-audit services (including the fees and other terms) to be
      provided to our independent auditors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, shareholders will be asked to approve the re-appointment of PwC, as the Company&#8217;s independent auditors for the year ending December 31, 2026, and its service until
      the annual general meeting of shareholders to be held in 2027.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Information on fees paid to the Company's independent public accountants may be found in Item 16C of the Annual Report on Form 20-F for the year ended December 31, 2025, which was
      filed with the SEC on February 10, 2026.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Proposed Resolutions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are therefore proposing to adopt the following resolution:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>,&#160;to approve the re-appointment of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member of
      PricewaterhouseCoopers International Limited, as the Company&#8217;s independent auditors for the fiscal year ending December 31, 2026, and its service until the annual general meeting of shareholders to be held in 2027.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">See &#8220;Quorum and Required Vote&#8221; above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 35.45pt; line-height: 1.25; font-weight: bold;">The Board unanimously recommends that you vote &#8220;FOR&#8221; the proposed resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL THREE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">APPROVAL OF</font>&#160;<font style="font-weight: bold;">THE GRANT OF RESTRICTED SHARE UNITS</font><br>
      <font style="font-weight: bold;">TO DR. SHLOMO NASS, DR. HADAR RON AND MR. NADAV KENNETH</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Background</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under Israeli law, any arrangement between a public company and its directors as to the terms of service require the approval of such company&#8217;s compensation committee, board of
      directors and shareholders. In addition, under the Companies Law, the compensation of directors must comply with a company&#8217;s compensation policy, unless such company&#8217;s compensation committee and board of directors conclude that a deviation from the
      terms of the compensation policy is warranted due to special circumstances. Under our Compensation Policy, equity-based compensation shall be individually determined and awarded based on the performance, educational background, prior business
      experience, qualifications, role and the personal responsibilities of the grantee.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Compensation, Nominating and Corporate Governance Committee has reviewed the abovementioned qualifications of each of Dr. Shlomo Nass, Dr. Hadar Ron and Mr. Nadav Kenneth, and
      determined, based on these criteria, that the grant of the equity awards proposed herein is in the best interests of the shareholders and the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Following the approval of our Compensation, Nominating and Corporate Governance Committee, our Board has approved the grant of 2,000 RSUs to each of the following non-executive
      directors: Dr. Shlomo Nass, Dr. Hadar Ron and Mr. Nadav Kenneth, under the Company&#8217;s 2018 Incentive Plan, totaling 6,000 RSUs, half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15, 2028, subject to
      each of their continued service on the date of vesting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The proposed grants are in compliance with the Company&#8217;s Compensation Policy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Proposed Resolutions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are therefore proposing to adopt the following resolution:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>,&#160;to approve the grant of a total of 6,000 restricted share units under the Company&#8217;s 2018 Incentive Plan to the following
      non-executive directors: Dr. Shlomo Nass (2,000 RSUs), Dr. Hadar Ron (2,000 RSUs) and Mr. Nadav Kenneth (2,000 RSUs), half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15, 2028, subject to their
      continued service on the date of vesting.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">See &#8220;Quorum and Required Vote&#8221; above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 35.45pt; line-height: 1.25; font-weight: bold;">The Board unanimously recommends that you vote &#8220;FOR&#8221; the proposed resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">As each of Dr. Shlomo Nass, Dr. Hadar Ron and Mr. Nadav Kenneth have a personal interest in the foregoing proposed resolution concerning the above equity grant,
      they each refrained from making a recommendation with respect to his or her own grant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL FOUR</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">APPROVAL OF</font>&#160;<font style="font-weight: bold;">THE COMPENSATION TERMS OF THE SPECIAL COMMITTEE OF THE BOARD</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Background</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On November 4, 2025, the Board appointed a special independent committee,&#160;composed entirely of the independent directors of the Board serving at the time: Dr. Michael Anghel, Dr.
      Hadar Ron and Mr. Nadav Kenneth (the &#8220;<font style="font-weight: bold;">Special Committee</font>&#8221;), to evaluate and oversee the potential sale process of the Company by way of merger, sale of shares, or sale of substantially all of the Company&#8217;s
      assets (the &#8220;<font style="font-weight: bold;">Transaction</font>&#8221;), including overseeing negotiations with potential purchasers presented to the Company by the investment bank selected by the Company to advise on the Transaction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In consideration for the time and effort required of the members of the Special Committee in connection with evaluating the potential Transaction, each of our Compensation
      Committee, Nominating and Corporate Governance Committee and our Board approved, on February 9, 2026, a set fee per meeting of the Special Committee (whether held in person or virtually, or by way of written resolutions), in accordance with the
      amounts provided in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director) 5760-2000, as amended, and the Relief Rules, including Section 5(f) thereof, which, as of the date of this Proxy Statement, is in
      the amount of NIS 4,660 per meeting for each member of the Special Committee (the fixed, modest per-meeting amount prescribed by these Israeli regulations for external directors, and not an amount set or negotiated by the Company or the members of
      the Special Committee), as compensation for their service on the Special Committee (the &#8220;<font style="font-weight: bold;">Special Committee Compensation</font>&#8221;). The Special Committee Compensation is in addition to the regular annual fees paid to
      our directors in accordance with our Compensation Policy and is not contingent upon the Special Committee's recommendations or upon completion of the potential Transaction or any other outcome of the transaction process.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Following a careful and thorough review of the final proposals received in connection with the potential Transaction, the Special Committee, acting in the best interests of the
      Company's shareholders and to protect shareholders from realizing inadequate value, unanimously concluded on February 23, 2026, that none of the final proposals reflected adequate value or was in the best interests of the Company and its
      shareholders. The Special Committee accordingly determined not to proceed with any of the proposals, in order to preserve the ability of the Company's shareholders to realize the full, long-term value of their investment. Accordingly, the mandate,
      authority and activities of the Special Committee in respect of such process were concluded by the Board on such date.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Special Committee conducted an extensive, comprehensive and independent process to evaluate the proposals received in connection with the Transaction, with the assistance of
      external financial and legal advisors, and held a total of 46 meetings. The aggregate compensation therefore reflects solely the volume of work undertaken by these independent directors across these meetings, multiplied by the fixed per meeting fee
      described above, and does not reflect any increase in the rate of compensation. Accordingly, the compensation for each member of the Special Committee, as approved by our Compensation, Nominating and Corporate Governance Committee and our Board, is
      in the amount of NIS 214,360, and an aggregate of NIS 643,080 for all members of the Special Committee.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Special Committee Compensation, as described above and as approved by the Compensation, Nominating and Corporate Governance Committee and the Board, exceeded the limits set
      forth in the Company&#8217;s Compensation Policy that was in effect at the time of approval and, therefore, in accordance with the Companies Law, requires that at least one of the following two alternative voting requirements be met as part of the approval
      by a majority of the ordinary shares present and voting thereon:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9378e695fc0246ab926c86849bd22027" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 14.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>approval by a majority of the ordinary shares held and voted at the Meeting by non-controlling shareholders who do not have a personal interest in the approval of the applicable proposal, excluding abstentions; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze8b512461a534430bfa78ce53f99ff46" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 14.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the total number of shares held by non-controlling, disinterested shareholders (as described in the previous bullet-point) and voted against the applicable proposal, does not exceed two percent (2%) of the aggregate voting rights in the
              Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"></div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Proposed Resolutions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are therefore proposing to adopt the following resolution:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>,&#160;to approve the compensation terms of the Special Committee of the Board, as set forth in Proposal 4 of this Proxy Statement.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">See &#8220;Quorum and Required Vote&#8221; above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 35.45pt; line-height: 1.25; font-weight: bold;">The Board unanimously recommends that you vote &#8220;FOR&#8221; the proposed resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">As each of Dr. Hadar Ron and Mr. Nadav Kenneth have a personal interest in the foregoing proposed resolution, being members of the Special Committee of the
      Board, they each refrained from making a recommendation with respect to this proposal.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OTHER BUSINESS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board is not aware of any other matters that may be presented at the Meeting other than those specified in the enclosed&#160;Notice of Annual General Meeting of Shareholders. If any
      other matters do properly come before the Meeting, it is intended that the persons named as proxies will vote, pursuant to their discretionary authority, according to their best judgment and in the interest of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ADDITIONAL INFORMATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company&#8217;s&#160;annual report on Form 20-F for the year ended December 31, 2025, which was filed with the SEC on February 10, 2026, as well as the Company's quarterly results for the
      quarterly period ended March 31, 2026, which were filed with the SEC on May 6, 2026, and other filings with the SEC,&#160;are available for viewing and downloading on the SEC&#8217;s website at&#160;<font style="font-style: italic;"><u>www.sec.gov</u>&#160;</font>as well
      as under the Investors section of the Company&#8217;s website at&#160;<font style="font-style: italic;"><u>www.inmodemd.com</u>.&#160;</font>Shareholders may obtain a copy of these documents without charge at&#160;<font style="font-style: italic;"><u>www.inmodemd.com</u></font>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company is subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221;),
      applicable to foreign private issuers. The Company fulfills these requirements by filing reports with the SEC. The Company&#8217;s SEC filings are available to the public on the SEC&#8217;s website at&#160;<font style="font-style: italic;"><u>www.sec.gov</u>.</font>&#160;As



      a foreign private issuer, the Company is exempted from the rules under the Exchange Act related to the furnishing and content of proxy statements. The circulation of this Proxy Statement should not be taken as an admission that the Company is subject
      to those rules.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">BY ORDER OF THE BOARD OF DIRECTORS</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Shlomo Nass</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Dr. Shlomo Nass</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Chairman of the Board</div>
            </td>
          </tr>

      </table>
      <br>
    </div>
    <div style="line-height: 1.25;">June 18, 2026</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; text-align: center;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 23.4pt; margin-left: 32.15pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; font-size: 16pt;">INMODE LTD</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Proxy for Annual General Meeting of the Shareholders on July 30, 2026</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Solicited on Behalf of the Board of Directors</div>
      <br>
      <div style="text-align: justify; margin-right: 27.1pt; margin-left: 36pt; line-height: 1.25;">
        <div style="line-height: 1.25;"> The undersigned, a shareholder of InMode Ltd. (the &#8220;Company&#8221;), an Israeli corporation, hereby appoints Mr. Moshe Mizrahy and Mr. Moshik Itzkovich, and each of them acting individually, as the
          attorney and proxy of the undersigned, with full power of substitution, for and in the name of the undersigned, to vote and otherwise act on behalf of the undersigned at the annual general meeting of shareholders of the Company to be held at the
          offices of the Company, Tavor Building, Sha&#8217;ar Yokneam Industrial Park, Yokneam, Israel, on July 30, 2026, at 5:00 p.m. Israel time (10:00 a.m. Eastern time), or at any adjournment(s) or postponement(s) thereof, with respect to all of the
          ordinary shares, of the Company (the &#8220;Shares&#8221;) which the undersigned would be entitled to vote, with all powers the undersigned would possess if personally present, provided said proxies are authorized and directed to vote as indicated with
          respect to the matter set forth below this Proxy. Subject to applicable law and the rules of Nasdaq, in the absence of such instructions, the Shares represented by properly executed and received proxies will be voted &#8220;FOR&#8221; all of the proposed
          resolutions to be presented to the annual general meeting or any adjournment(s) or postponement(s) thereof for which the Board of Directors recommends a &#8220;FOR&#8221; vote.</div>
        <div style="line-height: 1.25;"> <br>
        </div>
        <div style="line-height: 1.25;"> In accordance with the Israeli Companies Regulations (Reliefs for Companies with Securities Listed on an Exchange Outside of Israel), 5760-2000, a shareholder submitting a vote for proposal 4 is
          deemed to confirm to the Company that such shareholder DOES NOT HAVE a personal interest in such proposal and is NOT a controlling shareholder, unless such shareholder had delivered to the Company a notice in writing stating otherwise, no later
          than 11:59pm (Israel time) on the night prior to the Meeting, to the attention of the Company&#8217;s Chief Financial Officer, Mr. Moshik Itzkovich, at Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel, or via e-mail:
          Moshik.Itzkovich@InModemd.com. If you hold your shares in a &#8220;street name&#8221; (i.e., shares that are held through a bank, broker or other nominee) and believe that you are a controlling shareholder or possess a personal interest in the approval of
          Proposal 4, you may also contact the representative managing your account, who could then contact our Chief Financial Officer on your behalf, as described in the preceding sentence.</div>
        <div style="line-height: 1.25;"> <br>
        </div>
        <div style="line-height: 1.25;">This proxy also delegates, to the extent permitted by applicable law, discretionary authority to vote with respect to any other business which may properly come before the annual general meeting
          or any adjournment(s) or postponement(s) thereof.</div>
      </div>
      <div style="line-height: 1.25; text-align: justify;">&#160;</div>
      <div style="text-align: justify; margin-right: 26.95pt; margin-left: 35.95pt; line-height: 1.25; font-weight: bold;">
        <div style="line-height: 1.25;">WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, PLEASE COMPLETE, DATE AND SIGN THIS FORM OF PROXY AND MAIL THE ENTIRE PROXY PROMPTLY IN THE ENCLOSED ENVELOPE IN ORDER TO ASSURE REPRESENTATION OF
          THESE SHARES. NO POSTAGE NEED BE AFFIXED IF THE PROXY IS MAILED IN THE UNITED STATES.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-right: 23.4pt; margin-left: 32.15pt; line-height: 1.25; font-weight: bold;">(Continued and to be signed on the reverse side)</div>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; text-align: center;">
      <div>
        <div>
          <div style="line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS OF</div>
          <div style="line-height: 1.25; font-weight: bold;"> <br>
          </div>
        </div>
        <div>
          <div style="line-height: 1.25; font-size: 16pt; font-weight: bold;">INMODE LTD</div>
        </div>
        <div> <br>
          <div style="line-height: 1.25; font-weight: bold;">
            <div style="line-height: 1.25; font-family: Arial-BoldMT,serif; font-size: 12pt; font-weight: bold;">
              <div style="margin-right: 24pt; margin-left: 24.95pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">July 30, 2026</div>
              </div>
            </div>
          </div>
        </div>
        <div> <br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="4" border="0" align="center" style="width: 40%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

              <tr>
                <td style="background-color: #959595; border-bottom: 2px solid #000000; border-left: 2px solid #000000; border-right: 2px solid #000000; border-top: 2px solid #000000; width: 100%;">
                  <div>
                    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">PROXY VOTING INSTRUCTIONS</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 46%; text-align: left; vertical-align: top;">
                  <div style="line-height: 1.25; text-align: justify;"><u><font style="font-weight: bold;">INTERNEN</font></u><font style="font-weight: bold;"> &#8226; </font>Access <font style="font-weight: bold;">www.voteproxy.com </font>and follow the
                    on-screen instructions or scan the QR code with your smartphone. Have your proxy card available when you access the web page.</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 24%;">
                  <div>
                    <div style="text-align: left; line-height: 1.25;"><img width="57" height="57" src="image00001.jpg"></div>
                  </div>
                </td>
                <td style="width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 46%;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"><u>TELEPHONE</u> - </font>Call toll-free <font style="font-weight: bold;">1-800-PROXIES </font>(1-800-776-9437) in the United States or <font style="font-weight: bold;">+1-201-299-4446 </font>worldwide from any touch-tone telephone and follow the instructions. Have your proxy card available when you call.</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 2%;">&#160;</td>
                <td rowspan="1" style="width: 46%; text-align: justify;"><br>
                </td>
                <td rowspan="1" style="width: 2%;">&#160;</td>
                <td rowspan="1" style="width: 24%;">&#160;</td>
                <td rowspan="1" style="width: 24%;">&#160;</td>
                <td rowspan="1" style="width: 2%;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 46%;">
                  <div style="text-align: justify; line-height: 1.25;">Vote online or by phone until 11:59 p.m. Eastern Time the day before the meeting.</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td colspan="1" rowspan="2" style="width: 24%; border-color: rgb(0, 0, 0); border-style: solid; border-width: 2px;">
                  <div>
                    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">COMPANY NUMBER</div>
                  </div>
                </td>
                <td style="width: 24%; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 46%; text-align: justify; padding-bottom: 2px;"><br>
                </td>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 24%; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 46%;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"><u>MAIL</u> - </font>Sign, date and mail your proxy card in the envelope provided as soon as possible.</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td colspan="1" rowspan="2" style="width: 24%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ACCOUNT NUMBER</div>
                  </div>
                </td>
                <td style="width: 24%; border-right: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 46%; text-align: justify; padding-bottom: 2px;"><br>
                </td>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 24%; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 46%;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"><u>IN PERSON</u> - </font>You may vote your shares in person by attending the Annual General Meeting.</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="background-color: rgb(170, 170, 170); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="border-right: 2px solid #000000; width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 46%; text-align: justify; padding-bottom: 2px;"><br>
                </td>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="background-color: rgb(170, 170, 170); width: 24%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td rowspan="1" style="border-bottom: 2px solid; border-right: 2px solid #000000; width: 24%;">&#160;</td>
                <td rowspan="1" style="width: 2%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 46%;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">GO GREEN - </font>e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy material, statements and other eligible
                    documents online, while reducing costs, clutter and paper waste. Enroll today via <u>equiniti.com/us/ast-access</u> to enjoy online access.</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 2%;">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div> <br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; border-color: rgb(0, 0, 0); border-style: solid; border-width: 2px;">
                  <div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                      <div style="line-height: 1.25;">
                        <div style="text-align: center; line-height: 1.25;">
                          <div style="line-height: 1.25; font-family: ArialMT,serif;">
                            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS</font>:</div>
                            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Notice of Meeting, Proxy Statement and Proxy Card</div>
                            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">are available at <u>astproxyportal.com/ast/22993</u></div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <br>
        </div>
        <div>
          <div style="line-height: 1.25;">&#8595; Please detach along perforated line and mail in the envelope provided <u>IF</u> you are not voting via telephone or the Internet. &#8595;</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 100%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>
                      <div style="text-align: center; line-height: 1.25; font-family: Arial-BoldMT,serif; font-size: 7pt; font-weight: bold;"> <br>
                      </div>
                      <div style="text-align: center; line-height: 1.25; font-family: Arial-BoldMT,serif; font-weight: bold;">THE BOARD RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR EACH OF THE PROPOSALS.</div>
                      <div style="text-align: left; line-height: 1.25; font-family: Arial-BoldMT, serif; font-size: 7pt; font-weight: bold;">
                        <div style="text-align: center; line-height: 1.25; font-family: Arial-BoldMT,serif; font-size: 8pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">PLEASE SIGN, DATE AND RETURN PROMPTLY
                            IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#9746;</font></div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 3.17%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 22%;"><br>
                  </td>
                  <td style="width: 1%;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 3%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 29%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 1.08%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div style="font-family: 'Times New Roman',Times,serif;">
                      <div style="line-height: 1.25;">FOR</div>
                    </div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div style="font-family: 'Times New Roman',Times,serif;">AGAINST</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div style="font-family: 'Times New Roman',Times,serif;">ABSTAIN</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%; text-align: left; vertical-align: top;">
                    <div><br>
                    </div>
                  </td>
                  <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1%;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 3%; text-align: center; vertical-align: top;">
                    <div>1.</div>
                  </td>
                  <td style="width: 29%; text-align: left; vertical-align: top;">
                    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To re-elect Dr. Hadar Ron to serve as a Class I director of the Company, and to hold office until the annual general meeting of
                      shareholders to be held in 2029 and until her successor is duly elected and qualified, or until her earlier resignation or retirement.</div>
                  </td>
                  <td style="width: 1.08%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1%;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 3%; text-align: center; vertical-align: top;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 29%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1.08%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div>FOR</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">AGAINST</td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div>ABSTAIN </div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 3.17%; text-align: left; vertical-align: top;">
                    <div>
                      <div><br>
                      </div>
                    </div>
                    &#160;</td>
                  <td colspan="1" style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 1%;"><br>
                  </td>
                  <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                    <div>&#160;</div>
                    &#160;</td>
                  <td style="width: 3%; text-align: center; vertical-align: top;">
                    <div>2. </div>
                  </td>
                  <td style="width: 29%; text-align: left; vertical-align: top;">
                    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To approve the re-appointment of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member of PricewaterhouseCoopers
                      International Limited, as the Company&#8217;s independent auditors for the fiscal year ending December 31, 2026, and its service until the annual general meeting of shareholders to be held in 2027.</div>
                  </td>
                  <td style="width: 1.08%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744; </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1%;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 3%; text-align: center; vertical-align: top;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 29%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1.08%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div>FOR</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div>AGAINST</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: bottom;">
                    <div>ABSTAIN</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="2" style="width: 3.17%; text-align: left; vertical-align: top;"> <br>
                  </td>
                  <td rowspan="2" style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td rowspan="2" style="width: 1%;"><br>
                  </td>
                  <td rowspan="2" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td rowspan="2" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td rowspan="2" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td rowspan="2" style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 3%; text-align: center; vertical-align: top;">
                    <div>3.</div>
                  </td>
                  <td style="width: 29%; text-align: left; vertical-align: top;">
                    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To approve the grant of a total of 6,000 restricted share units under the Company's 2018 Incentive Plan to the following non-executive
                      directors: Dr. Shlomo Nass (2,000 RSUs), Dr. Hadar Ron (2,000 RSUs) and Mr. Nadav Kenneth (2,000 RSUs), half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15, 2028, subject to their
                      continued service on the date of vesting.</div>
                  </td>
                  <td style="width: 1.08%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3%; text-align: center; vertical-align: top;">&#160;</td>
                  <td style="width: 29%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1.08%;">&#160;</td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">
                    <div>FOR</div>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">AGAINST <br>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;">ABSTAIN <br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%;"><br>
                  </td>
                  <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td style="width: 1%;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);"><br>
                  </td>
                  <td colspan="1" rowspan="2" style="width: 3%; text-align: center; vertical-align: top;">
                    <div>4.</div>
                    <div><br>
                    </div>
                  </td>
                  <td colspan="1" rowspan="2" style="width: 29%; text-align: left; vertical-align: top;">
                    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To approve the compensation terms of the Special Committee of the Board, as set forth in Proposal 4 of the Proxy Statement dated June 18,
                      2026.</div>
                  </td>
                  <td rowspan="2" colspan="1" style="width: 1.08%;">
                    <div>&#160;</div>
                    <div>&#160;</div>
                    &#160;&#160;</td>
                  <td colspan="1" rowspan="2" style="width: 7%; text-align: center; vertical-align: top;">&#9744; </td>
                  <td colspan="1" rowspan="2" style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                  <td colspan="1" rowspan="2" style="width: 7%; text-align: center; vertical-align: top;">
                    <div>&#9744;</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 3.17%;"><br>
                  </td>
                  <td colspan="1" style="width: 22%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 1%;"><br>
                  </td>
                  <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                  </td>
                  <td colspan="1" style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 22%; text-align: left; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                  <td style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="4" rowspan="1">&#160;</td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                  <td style="width: 3%; text-align: center; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="3" style="width: 29%; padding-bottom: 2px;">
                    <div style="text-align: justify; line-height: 1.25;">
                      <div style="line-height: 1.25;"><br>
                      </div>
                    </div>
                  </td>
                  <td style="width: 1.08%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 7%; text-align: center; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%;" rowspan="1">&#160;</td>
                  <td style="width: 22%;" rowspan="1">&#160;</td>
                  <td colspan="4" rowspan="1">&#160;</td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                  <td style="width: 3%;" rowspan="1">&#160;</td>
                  <td style="width: 1.08%;" rowspan="1">&#160;</td>
                  <td style="width: 7%; text-align: center;" rowspan="1"><br>
                  </td>
                  <td style="width: 7%; text-align: center;" rowspan="1"><br>
                  </td>
                  <td style="width: 7%; text-align: center;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%;" rowspan="1">&#160;</td>
                  <td colspan="5" rowspan="1">&#160;</td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                  <td style="width: 3%; text-align: center; vertical-align: top;" rowspan="1"><br>
                  </td>
                  <td style="width: 1.08%;" rowspan="1">&#160;</td>
                  <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                  </td>
                  <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3.17%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td colspan="5" style="border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                  <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                  <td style="width: 3%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 29%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 1.08%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 7%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 7%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                  <td style="width: 7%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 3.17%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                  <td colspan="5" style="border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                        <div style="line-height: 1.25;">To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not
                          be submitted via this method.</div>
                      </div>
                    </div>
                  </td>
                  <td style="width: 2.03%; text-align: center; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>&#9744;</div>
                  </td>
                  <td style="width: 3%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 29%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 1.08%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 7%; padding-bottom: 2px;">
                    <div>&#160;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td rowspan="1" style="width: 2.4%; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 6%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 9%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 6%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 9%; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 2.4%;">&#160;</td>
                  <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                  <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 6%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                  <td rowspan="1" style="width: 9%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                  <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 6%; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                  <td rowspan="1" style="width: 9%; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 2.4%; padding-bottom: 2px;"><br>
                  </td>
                  <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                    <div style="text-align: center; line-height: 1.25;">Signature of Shareholder</div>
                  </td>
                  <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);"><br>
                  </td>
                  <td rowspan="1" style="width: 6%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                    <div style="line-height: 1.25;">Date:</div>
                  </td>
                  <td rowspan="1" style="width: 9%; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                    <div style="text-align: center; line-height: 1.25;">Signature of Shareholder</div>
                  </td>
                  <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 6%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                    <div style="text-align: center; line-height: 1.25;">Date:</div>
                  </td>
                  <td rowspan="1" style="width: 9%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
            <div> <br>
            </div>
            <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td rowspan="1" style="width: 5%;">&#160;</td>
                  <td rowspan="1" style="width: 4%; font-family: 'Times New Roman',Times,serif; text-align: left; vertical-align: top;">
                    <div style="line-height: 1.25; font-weight: bold;">Note:</div>
                  </td>
                  <td rowspan="1" style="width: 93%; font-family: 'Times New Roman',Times,serif;">
                    <div style="text-align: justify; line-height: 1.25;">
                      <div style="line-height: 1.25;">Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give
                        full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25"> <br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div>
            <div style="line-height: 1.25; font-weight: bold;"> <br>
            </div>
            <div style="line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS OF</div>
            <div style="line-height: 1.25; font-weight: bold;"> <br>
            </div>
          </div>
          <div style="line-height: 1.25">
            <div style="line-height: 1.25; font-size: 16pt; font-weight: bold;">INMODE LTD</div>
          </div>
          <div style="line-height: 1.25"> <br>
            <div style="line-height: 1.25; font-weight: bold; font-size: 12pt;">
              <div style="margin-right: 20.3pt; margin-left: 24.95pt; line-height: 1.25; font-size: 10pt; font-weight: bold;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">July 30, 2026</div>
              </div>
            </div>
          </div>
          <div style="line-height: 1.25">
            <div style="line-height: 1.25; font-weight: bold;"><br>
            </div>
          </div>
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td colspan="1" style="width: 33%;">&#160;</td>
                  <td style="width: 33%;">
                    <div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                        <div style="line-height: 1.25">
                          <div style="text-align: center; line-height: 1.25; font-weight: bold;">GO GREEN</div>
                        </div>
                      </div>
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                        <div style="line-height: 1.25;">e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy material, statements and other eligible documents online, while reducing costs, clutter and paper waste.
                          Enroll today via <u>equiniti.com/us/ast-access</u> to enjoy online access.</div>
                      </div>
                    </div>
                  </td>
                  <td colspan="1" style="width: 33%;">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25"><br>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u><font style="font-weight: bold;">NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS</font>:</u></div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Notice of Meeting, Proxy Statement and Proxy Card</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">are available at <u>astproxyportal.com/ast/22993</u></div>
            <div><br>
              <div>
                <div style="line-height: 1.25; font-size: 12pt;">Please sign, date and mail</div>
                <div style="line-height: 1.25; font-size: 12pt;">your proxy card in the</div>
                <div style="line-height: 1.25; font-size: 12pt;">envelope provided as soon</div>
                <div style="line-height: 1.25; font-size: 12pt;">as possible.</div>
              </div>
              <div><br>
                <div>
                  <div style="line-height: 1.25;">&#8595; Please detach along perforated line and mail in the envelope provided. &#8595;</div>
                </div>
                &#160;
                <div style="line-height: 1.25">
                  <div style="line-height: 1.25">
                    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                        <tr>
                          <td style="width: 100%; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); text-align: center; vertical-align: bottom;">
                            <div>
                              <div style="line-height: 1.25; font-family: Arial-BoldMT,serif; font-weight: bold;">THE BOARD RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR EACH OF THE PROPOSALS.</div>
                              <div style="line-height: 1.25; font-family: Arial-BoldMT,serif; font-size: 7pt; font-weight: bold;">
                                <div style="line-height: 1.25; font-size: 8pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR
                                    VOTE IN BLUE OR BLACK INK AS SHOWN HERE </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#9746;</font></div>
                              </div>
                            </div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height: 1.25">
                    <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                        <tr>
                          <td style="width: 3.17%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 22%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 1%;">&#160;</td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 3%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 29%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 1.08%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div style="font-family: 'Times New Roman',Times,serif;">
                              <div style="line-height: 1.25;">FOR</div>
                            </div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div style="font-family: 'Times New Roman',Times,serif;">AGAINST</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div style="font-family: 'Times New Roman',Times,serif;">ABSTAIN</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1%;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 3%; text-align: center; vertical-align: top;">
                            <div>1.</div>
                          </td>
                          <td style="width: 29%; text-align: left; vertical-align: top;">
                            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To re-elect Dr. Hadar Ron to serve as a Class I director of the Company, and to hold office until the annual general meeting of
                              shareholders to be held in 2029 and until her successor is duly elected and qualified, or until her earlier resignation or retirement.</div>
                          </td>
                          <td style="width: 1.08%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%;"><br>
                          </td>
                          <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1%;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 3%; text-align: center; vertical-align: top;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 29%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1.08%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div>FOR</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">AGAINST</td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div>ABSTAIN </div>
                          </td>
                        </tr>
                        <tr>
                          <td colspan="1" style="width: 3.17%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 1%;"><br>
                          </td>
                          <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);"><br>
                          </td>
                          <td style="width: 3%; text-align: center; vertical-align: top;">
                            <div>2.</div>
                          </td>
                          <td style="width: 29%; text-align: left; vertical-align: top;">
                            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To approve the re-appointment of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member of PricewaterhouseCoopers
                              International Limited, as the Company&#8217;s independent auditors for the fiscal year ending December 31, 2026, and its service until the annual general meeting of shareholders to be held in 2027.</div>
                          </td>
                          <td style="width: 1.08%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744; </div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%;"><br>
                          </td>
                          <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1%;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 3%; text-align: center; vertical-align: top;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 29%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1.08%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div>FOR</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div>AGAINST</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: bottom;">
                            <div>ABSTAIN</div>
                          </td>
                        </tr>
                        <tr>
                          <td rowspan="2" style="width: 3.17%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td rowspan="2" style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td rowspan="2" style="width: 1%;"><br>
                          </td>
                          <td rowspan="2" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td rowspan="2" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td rowspan="2" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td rowspan="2" style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 3%; text-align: center; vertical-align: top;">
                            <div>3.</div>
                          </td>
                          <td style="width: 29%; text-align: left; vertical-align: top;">
                            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To approve the grant of a total of 6,000 restricted share units under the Company's 2018 Incentive Plan to the following
                              non-executive directors: Dr. Shlomo Nass (2,000 RSUs), Dr. Hadar Ron (2,000 RSUs) and Mr. Nadav Kenneth (2,000 RSUs), half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15,
                              2028, subject to their continued service on the date of vesting.</div>
                          </td>
                          <td style="width: 1.08%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3%; text-align: center; vertical-align: top;">&#160;</td>
                          <td style="width: 29%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1.08%;">&#160;</td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">
                            <div>FOR</div>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">AGAINST <br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;">ABSTAIN <br>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%;"><br>
                          </td>
                          <td style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td style="width: 1%;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td colspan="1" rowspan="2" style="width: 3%; text-align: center; vertical-align: top;">
                            <div>4.</div>
                          </td>
                          <td colspan="1" rowspan="2" style="width: 29%; text-align: left; vertical-align: top;">
                            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">To approve the compensation terms of the Special Committee of the Board, as set forth in Proposal 4 of the Proxy Statement dated
                              June 18, 2026.</div>
                          </td>
                          <td rowspan="2" colspan="1" style="width: 1.08%;">
                            <div>&#160;</div>
                            <div>&#160;</div>
                            &#160;&#160;</td>
                          <td colspan="1" rowspan="2" style="width: 7%; text-align: center; vertical-align: top;">&#9744; </td>
                          <td colspan="1" rowspan="2" style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                          <td colspan="1" rowspan="2" style="width: 7%; text-align: center; vertical-align: top;">
                            <div>&#9744;</div>
                          </td>
                        </tr>
                        <tr>
                          <td colspan="1" style="width: 3.17%;"><br>
                          </td>
                          <td colspan="1" style="width: 22%; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 1%;"><br>
                          </td>
                          <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 6.14%; text-align: center; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);"><br>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%; padding-bottom: 2px;"><br>
                          </td>
                          <td style="width: 22%; text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                          </td>
                          <td style="border-bottom: 2px solid rgb(0, 0, 0); width: 1%;"><br>
                          </td>
                          <td style="border-bottom: 2px solid rgb(0, 0, 0); width: 6.14%;"><br>
                          </td>
                          <td style="border-bottom: 2px solid rgb(0, 0, 0); width: 6.14%;"><br>
                          </td>
                          <td style="border-bottom: 2px solid rgb(0, 0, 0); width: 6.14%;"><br>
                          </td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 3%; padding-bottom: 2px; text-align: left; vertical-align: top;"><br>
                          </td>
                          <td colspan="1" rowspan="4" style="width: 29%; padding-bottom: 2px;"><br>
                          </td>
                          <td style="width: 1.08%; padding-bottom: 2px;"><br>
                          </td>
                          <td style="width: 7%; padding-bottom: 2px; text-align: center;"><br>
                          </td>
                          <td style="width: 7%; padding-bottom: 2px; text-align: center;"><br>
                          </td>
                          <td style="width: 7%; padding-bottom: 2px; text-align: center;"> <br>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%;" rowspan="1">&#160;</td>
                          <td style="width: 22%; text-align: left; vertical-align: top;" rowspan="1">&#160;</td>
                          <td colspan="4" rowspan="1">&#160;</td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                          <td style="width: 3%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                          <td style="width: 1.08%;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%;" rowspan="1">&#160;</td>
                          <td style="width: 22%;" rowspan="1">&#160;</td>
                          <td colspan="4" rowspan="1">&#160;</td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                          <td style="width: 3%;" rowspan="1"><br>
                          </td>
                          <td style="width: 1.08%;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center;" rowspan="1"><br>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%;" rowspan="1">&#160;</td>
                          <td colspan="5" rowspan="1">&#160;</td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                          <td style="width: 3%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                          <td style="width: 1.08%;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                          <td style="width: 7%; text-align: center; vertical-align: top;" rowspan="1"><br>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td colspan="5" style="border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                          <td style="width: 2.03%; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                          <td style="width: 3%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td style="width: 29%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td style="width: 1.08%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td style="width: 7%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td style="width: 7%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td style="width: 7%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width: 3.17%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                          <td colspan="5" style="border-bottom: 2px solid rgb(0, 0, 0);">
                            <div>
                              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                                <div style="line-height: 1.25;">To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account
                                  may not be submitted via this method.</div>
                              </div>
                            </div>
                          </td>
                          <td style="width: 2.03%; text-align: center; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                            <div>&#9744;</div>
                          </td>
                          <td style="width: 3%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 29%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 1.08%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 7%; padding-bottom: 2px;">
                            <div>&#160;</div>
                          </td>
                        </tr>

                    </table>
                    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                        <tr>
                          <td rowspan="1" style="width: 2.4%; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                          <td rowspan="1" style="width: 6%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 9%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 6%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
                          <td rowspan="1" style="width: 9%; padding-bottom: 2px;">&#160;</td>
                        </tr>
                        <tr>
                          <td rowspan="1" style="width: 2.4%;">&#160;</td>
                          <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                          <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                          <td rowspan="1" style="width: 6%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                          <td rowspan="1" style="width: 9%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                          <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                          <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                          <td rowspan="1" style="width: 6%; font-family: 'Times New Roman',Times,serif;">&#160;</td>
                          <td rowspan="1" style="width: 9%; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
                        </tr>
                        <tr>
                          <td rowspan="1" style="width: 2.4%; padding-bottom: 2px;"><br>
                          </td>
                          <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                            <div style="text-align: center; line-height: 1.25;">Signature of Shareholder</div>
                          </td>
                          <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);"><br>
                          </td>
                          <td rowspan="1" style="width: 6%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                            <div style="line-height: 1.25;">Date:</div>
                          </td>
                          <td rowspan="1" style="width: 9%; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
                          <td rowspan="1" style="width: 15%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                            <div style="text-align: center; line-height: 1.25;">Signature of Shareholder</div>
                          </td>
                          <td rowspan="1" style="width: 19%; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
                          <td rowspan="1" style="width: 6%; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
                            <div style="text-align: center; line-height: 1.25;">Date:</div>
                          </td>
                          <td rowspan="1" style="width: 9%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
                        </tr>

                    </table>
                    <div> <br>
                    </div>
                    <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                        <tr>
                          <td rowspan="1" style="width: 5%;">&#160;</td>
                          <td rowspan="1" style="width: 4%; font-family: 'Times New Roman',Times,serif; text-align: left; vertical-align: top;">
                            <div style="line-height: 1.25; font-weight: bold;">Note:</div>
                          </td>
                          <td rowspan="1" style="width: 93%; font-family: 'Times New Roman',Times,serif;">
                            <div style="text-align: justify; line-height: 1.25;">
                              <div style="line-height: 1.25;">Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian,
                                please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized
                                person.</div>
                            </div>
                          </td>
                        </tr>

                    </table>
                    <div> <br>
                    </div>
                    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %6 T8# 2(  A$! Q$!_\0
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M'I-KXE^]DG;:#MR7OO/5;\K1XF-SO#X>\*%L35V]U_NHOSFK\S\H771R3/\
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M$_A5X-LHY_L]SX@OLZMKUY!!).-(\+>';-+G7O%&M3K&5MM*T+3[Z]E<J!$
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MIS+22[QDM)1_O1;7F?0T,11Q$%4H5(U(]XO5/M);QEY22?D6J***Q-@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "F2RQPQR332)%#$C22RRLL<<<: L[R.Y"HBJ"S,Q"J
M22 *_,/_ (*!_P#!7G]BK_@G'H%R?C7\1[77OBA+:B?0/@7\/Y[#Q%\4=9:5
M)C;37NCI=QV_A31YFA=3KOBJZTG3V(\NT:\N6CMI/X!O^"DW_!P9^VI^WZVM
M^!/#^LW'[.'[.]]-+%'\*_AKK5Y%K?B330Q2./XB_$"WCTO6O$J7$>3=Z'81
M:+X7<.(;G2+YHTN6[\'EN)QC3A'DI-V=:::A_P!N]9ORCIW://QF98;!)J<N
M>KTHP:<_+FZ07G+5KX5(_L$_X*5_\'(O['O[$X\1?#?X*W-C^U-^T/IDLVFS
M>&?!NLI'\,_!NJ12/!.OC?XB6D5]97%W82QR)<>'?"D>LZJMR@M-2FT7?]H3
M^!C]NO\ X*>?MC?\%$/&$_B']HOXJ:KJ'A:WOGN_#/PC\,S7?A_X3>$ "XMA
MH_@ZWNI;2[U&"-WB_P"$AU^36/$4JO(DNK-"1"OS[^S?^RO^T+^UY\1+'X5_
MLW_"7QA\6?&UX8VGT[POIKSVFC6DK.O]J>)]<G,&B^%]&3RY!)JNO:AIUCO4
MQ+,TQ2-O[D?^":__  :H?"/X5?V)\4O^"@NNZ9\;_':+9:C:? WPG<ZC:?";
MPW>H8[@P>+=<5['5_B-<0R*(9M/2WT;PLZ^=!=6FO6\BRCWE3RS)XWF_;8FV
MFD95=;:PC=PI+?WI/F:T4I.Z/!=3,\Y;C!>PPM[/5QIVZJ4[<U:2ZQ2Y;[QC
MN?R,?L!_\$F?VT_^"C7B6*T^ _PSN]/^'MM=PQ>(_C9X\CO?#/PKT")Y)5E6
M'7IK.:7Q/JL0@F!T+PG9ZWJ44GD#4(M.MIUNQ_?K_P $U_\ @WA_8O\ V#(]
M!\?^.=)M/VFOVB;&&SNI/B/\1M#LIO"GA368HT::;X:_#ZZ;4=+T!H+G>;+7
M=6FUOQ/"F/(U6S5W@K]W?"?A+PKX#\.:/X/\$>&]"\(>$_#UA;Z7H/AKPUI5
MCH>A:-IMI&L-M8Z9I6FP6UC96L$2JD4%O!'&B@ +70UXV,S;%8N\;^QHO_EW
M3;O)62]^>\MOATCWBVKGM8+*<+@[3M[:LO\ E[42]U_].X:J'KK/?WK.Q^&?
M_!2/_@@/^Q/_ ,%!X-7\:6WAV#]GW]H2YM[R2U^,/PPT>PLH=>U26%%MI?B5
MX,A^PZ/XVA66& 3:@9-*\4"W$D-OXABC<H?X O\ @H7_ ,$<OVU_^"<&MW4_
MQ;^'\_C'X1375S'H/QX^'%MJ'B#X<WUO'/Y=JOB&YCM1>^ ]8N(GA?\ LCQ9
M!8I+,TL6CZCK$=M/<#_7)K*US0M$\3Z1J/A_Q)H^E^(-!UBTGL-6T76K"UU3
M2=3L;F-HKBSU#3[Z*>TO+6>-FCF@N(9(I$8JZD$BE@\UQ.$M#F=6BK?NIMVB
ME_S[EO#T5X[^[?4>-RK"XR\G'V59_P#+VFE=O^_'13]7:7:21_CJ_L4_\%%?
MVNO^"?OCB+QE^S/\6M;\*V4U]%=^)OAYJ,L^M_##QPD9A#V_BSP3=3C3+V2>
M*!+4:S8C3O$5E!F/3=:LMQ)_O5_X)J_\',_[)O[70T'X:?M-?V7^RG\>;Z6W
MTVWEU_57E^#'C34)6$,+^'_'5\D">%+N]E:-4T+QH]HBSRI:Z?KVL/\ ,/$?
M^"E7_!K%\ _CQ_;7Q1_85U72?V<?BE,;[4KWX5ZJM]=_!/Q?>O'+,EOI(B>Z
MU3X975Q=>6BOI%OJOAB")W2+PU9\7"?PK?M4?L:_M,?L4_$.Y^&'[3/PB\6?
M"[Q*DMT-+GUJQ:7PYXIL[5XT?5?!GBNS-QX?\5:7MF@=[O1;^Z^S>?';W\=I
M=%K=/::RS.(W7[G%65[*,:K>B?,K\M:/][XDK*\&>&I9GDKM)>WPM[*]Y4M;
M;/XJ,NEG[K=[*>Y_L]6US;WEO!=V=Q!=VMS$D]M<VTJ3V]Q#*H>.:":)FCEB
MD0ADDC9D=2&4D'-22,R1R.D;2NJ,R1*55I&525C5I&5%9R H9V5 3EF R:_R
ME_\ @F__ ,%X_P!MG_@G?<:7X0L/$S_'3]GZVGB%W\$?B=JE[>6FDV8\M9T^
M'?B]X[[7? <WE1[8+&W74_"L;EYG\,R3RO/7^@#_ ,$[O^"T?[$G_!1W2[+2
M_ACX\B\ ?&<P;]6^ OQ,N].T'X@Q2QQJ]S+X85KDZ;X[TN+<&.H>%KF]EMT9
M?[3L=-F)A'AXS+,5@_>E'VE+I6IIN*6C]];P>MM?=;T4F>]@LTPN-24)>SK=
M:-2REY\CVFO\/O6UE&)Y)^U]^U#^TA_;NH_#_4?#FL_!7PX9)HX;:QN)&U;Q
M-8ABBW+>+[/;;7=A.FTR6OAV:.W1G>SOKF[*,H_.[0= U[Q7JUKH?AS2-2U_
M6M1F$-GIFEVEQJ%_=2NPXC@MTDE;'WI)"H1%#/(RJ"1_51XV\!>#OB/H-SX9
M\<>'=,\2:+=@[[/4K<2>5)@JMS9W"[;FQO(P28;RSF@N8B<QRKS7(?"GX%?"
MWX*Z?-8?#SPI9Z/)=$_;M6F:74==OQN++'=ZQ>M-?26\9/[JT65+2(Y:.!79
MV;SCN<6WOI^/^1^:?P%_X)NWMX+3Q'\>-0DTZWW1SQ> M!O(VO94P'\O7]=M
MR\5F"<I+9Z,TLY7D:I;/NC'Z->(OV;_@CXF\%6_P_P!0^'/AN#PY8QR+I<6F
M:?!IM_I$\BA7OM-U2T2._M[^0JKW%T9W>]=?].^TJ65O;Z*+E))=#\*/CW_P
M3S\?> ?MWB'X537?Q$\*PK)</I BC7QII<*C<R"QMU6'Q$B+DB32HH;Y^$&D
ML%,K?GQ;W&K>']4CNK2;4=%UG2;L-#/!)<Z=J>G7ULY!9)8S#=6EU!(I!VF.
M:-@1P0:_K>KYB^.G[)?PD^.T,][K>DC0/&!A*6OC3P_'%:ZJ'4?NAJL&T6>N
M6ZG"F/4(WN4B+):7EH6W@)<.VGE_7_!/SF^ ?_!1CQ7X6^P>&OC/:3^,]!0I
M;IXNL@B>+-/AZ"348"8[7Q!%$,!Y";+4O+5I9+C49B$;]?/A]\2_ OQ3T&'Q
M)X!\2Z;XCTJ4*)'LIA]JLIF4.;74["0)>Z;>(&!>UO8()@"&"E&5C_/K\=OV
M/_BW\#)+G4+[36\5^"XV9HO&7AVWGGLK> $X.NV($EWH,OW2S7/FZ<698X=2
MGDRJ^$>!/B'XT^&>O6WB;P+XCU+PUK%N1_I&GSLL=S$"?]'O[.0/9ZA:,<E[
M2^AN+=SR8\@$.U_Z[V7ZZDJ4EI)?Y_\ !_K4_J[K\//^"U__  42_;$_8$^#
M$/BC]EW]DG7_ (MQ:M8WJ>(?CU>QIXD^'GP;<1R>1>>(/ OAJ[F\7WSJJM<#
M5M=B\.^"[-A#'=:O?SS#3V]]^ 7_  4;\.^(OL/AKXW64'A76G*6\?C33(Y&
M\,7KDJB2:M8YENM!D8G][<QO>:;D--*VG0_(OZ8V5]HOB;2(KW3[K3-?T+5[
M3=#=6DUKJ>E:E97"%28Y8FFM+NVF0E3AI(W4E3D9%72E&$XSG356,7=PDY*,
MO)N+3_-=TUH.HG4ISC3J.G*2LJD5%R@^Z4DU]ZVV:=FO\7C]H_\ :E_:&_:^
M^)5]\5/VB_BKXR^+7CC4I95MKWQ-J=Q=66C6MP\;#1O">@Q>7HWA?14=(O*T
M7P]86%@95\XV[W,DDTG[)?\ !-G_ (-S_P!L_P#;F?P]\0OB9IEW^R]^SQ?7
M"7#^-/B'HMW%\0?%>E1RE9'\ ?#B\%CJ<\5VL;I9^(?$\NA:(T3P:CIO]OVV
MV&7^^GPG_P $B?\ @G)X(_:.U+]JOPS^RG\,M.^,6HO'>1WXTR6X\*:/KHN)
M+J;Q5X=^']S/+X)T#Q7=S2>9<Z_I6A6NH>8OGPRPW,US-/\ I  % 50%50 J
M@8  &  !P !P . *]ROGG[J%+!45ATH6YGRODNM53@ER*W\S6O\ *M#PJ&11
M]K*MC:\L3)R;Y5S)3VM*I)MR;>SBK)?S-:'YD?L.?\$AOV%_V!?!-QX:^$/P
M=T'Q)XHUO29M'\:_%7XFZ;I7C3XB>,[.\A2'4M/U#5M1L#:Z7X?O@O[[POX?
MLM*T!@29K">9Y9I/Q^_X*6?\&N'[.?[12^(?BE^Q1?:1^S-\8;A);]_AR]K(
MWP'\77R1,?LUOI-A$^H?#2[O9%C'VWPW%?>'H6\R1O"GFSRW2_U<T5Y%/&8F
ME5]M"O455_%)R<N?RFI74UY2NNVQ[%3!X:K15"=&FZ45:,5%1Y/.#C9P?G%I
M]S_&1_:X_8@_:C_89^(=U\-/VFOA%XG^'.L)/*FCZU=6KWO@OQA;1E]NI^#/
M&=DLWA_Q)931IYK?8+Q[VS!,&IV=C=));1_='_!.+_@N7^VU_P $Y[W2?#7A
MKQ;)\8_@);RI'?? KXGZGJ6I>'M/L04$H^'VN&6?5OA_>A%'D1Z7]J\.^89)
M+SPW>3.9!_J2_'/]G_X*_M,?#O6OA1\>_AGX1^*GP^U^'RM1\->+])M]3L_,
M4AH;VQED47>E:I:2!9K+5=+N+/4;*=$FM;J*10P_B6_X*5_\&HGBGPO_ ,))
M\6?^"<OB.?QCH$4<FI3?LU^/=34>+K!46:2YMOAS\0-1N8[3Q''A818^'_&!
MLM6SYP'BG5)GM[0>_0S7"8R"P^84H1OISVO2;LE>[?-1EUYD[::S6Q\]7RG%
MX*?UC+JLY):NG=*JEVM\%:/]UI/:T9/4_I$_X)S_ /!;S]B3_@HS8:3X=\$^
M-8OA;\>)[%9=5^ OQ+O;/2/%CWD4+27P\$ZG(T.D?$+3K<)),+CP]*VJ0V>R
MXU71=+8M$G[#5_B2>,O!'Q3^!'Q"OO"/COPSXW^$GQ0\$:L@OM#\0Z9K/@[Q
MEX9U>SD6:VG^RW<6GZKIURCI'<V-Y"(RZ>5=6DSQ/%(?Z7/^":?_  =!?M,?
MLQCPY\+/VPK+5?VH?@I816NE6_C&6]@@^.G@W3(8EAMY8_$%Z5L_B-;6B)&C
M67BR:VU^=#),?%DC)':R<^+R.45[7!3]M3:YO9MQ<TN\)KW*BVLKJ5FDN=ZG
M3A,]A)^RQT/85$^5U$I<E]K3B_>ION]8K5OE1_H_T5\@?L??MX_LI_MW^ (?
MB%^S)\7O#/Q!LH[:VE\0>&8KN/3_ !YX*N;E<KIWC3P5>O%K_AV[#!EC>]LU
MLKP*9M/N[RW9)F^OZ\&490DXSC*,D[.,DXR3[-.S3]3Z",HSBI1:E%JZE%IQ
M:[IK1KT"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKZ)HHKP6W)MR;;;NVVVVWNVWJV>^DHI1BE&*2225DDMDDM$ET2"BBBD,*"<
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M(].AO])UO1+^QUS0=<TJ^B#P7=AJ%E+<V&H6-U"X9)H)989HVX+ U\+?'O\
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M ,H66>7P!K]XQ.0-RP^'=>N2>N"L=EKDOWCG^UPNV(8W_K[O\C1P:UBW^O\
MP?3Y:GU)\!/VXOA5\9!9:'K4\?P^\=3LL T'7+I/[+U2X.Q570===8+:ZDF=
MPL6GWBV6HL^8X8+I5$S_ &K7\EWB7POXC\&ZO=Z!XJT35/#VMV#^7=:7J]G-
M8WD)YVOY4Z*S0R8+0SQ[H9D(DBD=#D_7WP#_ &YOBI\'S8Z%X@GD^(/@2%DB
M.CZS<N=:TJV#88:%KLOF7$:QJ1Y5AJ7VVQ"J(+9;$%I @4^DOO\ \U_7H?T)
MT5X7\&?VC?A7\==.6Y\$Z_&-7CB\W4/">K>58>)M-P!YAFTXRR"ZMT)V_;].
MEO+$M\OV@2!D7W2@TN%%%% 'P-^W/_P3._8]_P""AW@J?PM^T?\ "O2]7U^"
MR>U\+_%+P\L7A_XI^"Y2?,AFT#Q?:0F\>UBF DDT/6$U7P]>_,E[I5PKFOX'
M?^"E?_!MA^U]^Q>WB/XE_ :&_P#VI_V>=.62_?5?"FER'XN^#=,WW#RCQE\/
MK".:76+/3X%@-QXD\&MJ,,BO/>7^B:#:6[&O]-N@C(((R#P01D$'J"*[L'F.
M)P3_ '4[T[WE1G=TWW:7V9/^:-GWOL<.,R[#8U?O8<M1*RK0M&HK;)NS4HK^
M62:72SU/\3SX,_''XR_LW?$32/BA\#OB-XQ^$_Q&\.SEM/\ $OA#5KO1=4@V
M2@S6-\L3+!J.FSO&([_1M5M[S3+Z-3!?6<\1,=?VJ_\ !-+_ (.O-'U4>&_A
M)_P4?\.QZ%J/E6FEVW[2_P /](DDT6^F&8([WXF> --B>?1Y9B(C>^(/!D5S
MIC3RR7$OAC1K)'E7]F/^"D__  0!_8L_X*"1Z_X[T[0H_P!GW]HS4+:66W^+
MWPXTVVM[#Q#JB1M]F?XD>!T:VT3Q9#(^Q+S5;;^R/%;P!477RD4<-?P!?\%"
MO^"/G[:?_!-[7+V7XQ^ )?%'PE:]^SZ!\>OA]!?:[\,]4BN+DV]C'K%Z+9+[
MP7K%RS6\?]C^*K336DNIE@TN[U9!]H?WHULMS=*%9>QQ#LHW<8U.9Z7IU;6J
M+^Y)7?\ +IS'S\J&9Y/)SHR=?"IWDDG*G;JZE*[=-]YP=MKS^R?ZROPQ^*GP
MV^-/@C0?B5\)/'7A;XD> ?$]FE_H'B_P;K=AX@T'5+5Q]^UU'3IIX&DC;,<\
M#,MQ;3*\-Q%%*CH.^K_')_8B_P""D'[7O_!/?QM'XO\ V:OBQJWAK3;F[AN/
M$_PZUG=K_P ,/&L*,GFV_B3P;>R?89)98U$(UG2FTKQ':Q@BQUFUY!_O;_X)
MI?\ !R[^R5^V)_PCOPR_:,;3_P!E?X_WZVVGHOB75(_^%.>-M7D;R47PGXYO
MI(O[ O+^0Q&WT#QDMA)]HN%L--UC7)5$C^3C<HQ.%YIQ3KT4_CA%\T5NN>&Z
M=MVN:*W;6Q[&"SC#8NT)/V%9V7)-KED_^G<]%*[VB^63Z)[G]+=%0V]Q!=P0
MW5K-#<VUS%'/;W%O(DT$\$J"2*:&:-FCEBE1E>.1&9'1@RD@@U-7DGK!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(>A^A_E0!_D
MX_\ !8[_ (*7?M0_MM?M2_&KP/\ $7X@:WI_P/\ A?\ &#QQX1^&_P %M&OI
MM/\  NB6'@GQ'J/AG3]:U/2K8QQ^(_%=]%I9U"\UW6S?7%I=WMU;:2=/T\I:
MCYZ_80_X)>?MD?\ !17Q5_8O[./PPN]0\)V%_%8^*OBUXJD;PY\+?![.-\G]
MJ^)[F"7^T;^*/;(V@^&[37-?VR0R'35@<3+\^_M=Y_X:P_:>_P"SA_C3QV/_
M !<KQ)T]#S@G\>_/^HW_ ,$%+>WM_P#@D7^Q)Y$$,'G_  RU6XG\F)(_.N)/
M'?BSS)Y2BKYDTF!OE?+O@;F.!7V.+Q/]FX##K#4Z<744([+E3]FINHXKXY-]
M92W^*^Q\7@\-_:>/Q#Q56I)4W*32>LDJG+&"D_@@NT5MHK;GRC_P38_X-P/V
M-_V(O[%^(GQ?M;/]JG]H&R^Q7T7BCQ[H=I_PKCP7JULT%PLO@#X>7/VVS2ZM
M;R$2VOB'Q1/K>M0NJRZ<='#/"?Z)T58U5$541%"(B*%5%4 *JJ  JJ
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M96"&?_@E;^WLL\,4RQ_LS_$N>-9HTD5)X-$EE@F0.&"RPRHLD4@ >.15="&
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MKS^T/\:>00,#_A9/B4]>3]>.W6O]2'_@@U_RB*_8?_[)9J/_ *G7BVO\M_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/$O7/7GIZ<@5_J1?\$&O^41?[#__ &2W4>G3_D>O%O2O\MS]KK_D[']IX?\
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M_DB7C7_LJ6I?^HIX1Z^_:OS+_;&Q_P --?%_/_0RP?\ IFTO\?Y9_#G]-/\
M@F'_ ,D3\:_]E1U'_P!1+PA5/9._9?@O^&^7W9Q^.7S_ #/TCHHHJ30****
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M -$I5NJEA_QXV7_7I;?^B4JW7RY]2%%%% !1110 4444 ?S4?MC?\G-?%_\
M[&2'/!Z?V-I77\?I7Z9_\$PO^2)>-?\ LJ6I?^HIX1K\S/VQO^3FOB^,$_\
M%2P?^F;2_;/;U[#TK],_^"87_)$O&O\ V5+4O_44\(__ *Z;_1?DC./QR^?Y
MGZ24444C0**** "BBB@ K^2S_@\#_P"3#OV=/^SL-*]?^B2?%'_]7I7]:=?R
M6?\ !X'_ ,F'?LZ?]G8:3_ZJ3XH].G-=V6_[_A?^OT3AS/\ W#%_]>9'\PO_
M  ;=$_\ #X3]ED=OL_Q>QC_LCOCCU^M?ZIM?Y67_  ;=_P#*87]EK_KV^+F1
MV_Y([XXZ?AU_4GBO]4VNS/O]^7G0IO\ &9Q9!_N#_P"O]3\H!1117BGMA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRT#X$T>EVTP5A^@D444$4<,$<<,,2+'%%$BQQ11H J1QQH J(B@*JJ J@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "LW6=&T?Q%I6H:%X@TG3==T/5[2?3]5T;6+&VU/2M3L+
MF-HKFRU#3[V*>TO+2XB9HYK>XADAE1BCHRDBM*B@#^4+_@I5_P &MO[.7[0Z
M^(OBC^Q+?:3^S+\7[E)K^3X;R6\[_ ;Q=J"J[F"VTJR274/AG=7C"*-;CPS!
M>^&X&4R'PHLLTUW7\)O[6_[$/[4'[#?Q$N/AG^TW\)?$OPYUS?(=(U:[MOMW
M@[Q=9H6VZCX.\86/GZ!XALF5-[BPO6O+//DZC:65R&@7_9OKQSX[?L^?!/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5\ _MT?\ !,C]CK_@HAX-F\-?M'?"K2]6
M\1VUA+9^%OBKX=6/P_\ %3P7(VYX)M!\7V<7VN:S@N"+A] UI-5\.7K K?:3
M<*QK[^HJH3G3DITY2A.+O&46XR3[IK5$SA&I%PG&,X25I1DE*+79IW3^9_F1
M_P#!2K_@VQ_:_P#V+V\1?$GX$17W[4_[/>G13ZE+K/A32V7XL^#-+A\QYO\
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ME2:/X0N%*^7/X(\ VJSZ#H^H1;<QZYJ<FNZ] S2_8-2L89&@K][U 4!5 55
M5548"@#   X  X ' %&*SNT?8X""I02Y55<4FE9K]U3V@M79N_E"+U#"9'>7
MML?4=6HWS.FI.2;[U:C]Z;[I-+^]):'P%^PG_P $ROV/O^"=G@J'PO\ LY?"
M_3M,\175A#9^*_BMXC6'7_BIXWD0^9++K_BVX@2YBLY;@M/%H&BQ:5X<L20M
MCI, 7G[^HHKY^4Y3DYSE*<Y.\I2;E*3[MO5OU/H8QC"*A",80BK1C%*,8I=$
ME9)>@4445)1B>(O#?A_Q=H]YX?\ %&BZ;K^B:A'Y5[I>K6<%]97"=1YD%PCI
MN1L-'( )(G >-E=0P_*WX]_\$W8)OMWB3X#7ZVTN7N)/A_KUVQMGXRT7A[7K
MEI)87/\ RQL=:DDA+L?^)M;QJD5?K;10)I/='\F7BKPEXG\#:Y>^&_%VAZEX
M=UW3VV7>F:K:R6MS&"2J2('&V:WDVDP75N\MM.F'@EDC(8]'JWQ<^)VO>$M.
M\!ZSX[\3ZGX0TM@UEX>O-6NIK",+M\F-T9R]S;VVQ19VUT\UO8C_ (\XH<FO
MZ6OBE\&OAQ\9=$;0OB#X9LM:A5'%EJ&W[-K.DR-SY^E:M!LO+*0, 72.0V\X
M!CN89XF>-OA?0_\ @F)\-K'Q0=1UKQ[XHUWPI%/YUMX:%E9:9?2(&REKJ/B"
MVF=IH-OR2M8:;IEQ(.8I[=ADN_\ 6^NG]?@9N#3TV?Y>9^1GPW^%/Q ^+>MK
MX>^'_AC4?$.H#RVNGMHQ%I^FPN2%N=5U.<Q6.G6[;7"27<\?F,IC@664A#^O
MOP'_ ."=/@SPA]B\0_&*[@\=^(56.=?#-KYT7@_3KCARET6$-YXB>)\K_I*V
M>F2 LLNFW(V2#]!?!W@CPC\/M$M?#G@OP]I?AO1;-0L-CI=JD",P4*9KB09G
MN[J0 &:[NI9KF9LO+*[$FNIHO_7]?UT*4$M]7^!5L;&RTRSMM/TVSM=/L+.&
M.WM+*RMXK6TM;>)0D4%O;0)'##%&H"I'&BHJ@!0!5JBBD6%%%% 'X@?\%(O^
M""7[$W_!0R'5O&<GAQ?@+^T)=":XA^-7POTRQLKC7KYHMJ+\1O"(%OH7C:WD
MD2'S]1F33_%4<<?EVGB*")Y8I/X ?^"B7_!&;]M?_@F]JE[JGQ6\#CQM\&/[
M3>RT+X]?#B.\UOX?WD,LS+IZ^)$:%=6\!ZK=1>2KZ=XFL[:S>^D:RTG5]9"K
M/)_K>UF:SHNC^(]*U#0O$&E:=KFB:M:S6.J:1J]E;:EIFHV5PACGM+ZPO(IK
M6[MIHV*2P3Q21R*2K*0:]+!YIB<':*?M:2T]E4;LEVA+>'IK&^O*V>9C<JPN
M,O-Q]E6?_+VFDFW_ 'X[3]7:5M%)(_QG_P!FC]N/]KC]CN?Q++^S)\?OB)\'
M8_&&FW.E>)-/\+:NHT75H;J(0-=SZ#J4&HZ+'K5O& NG^(H+"+Q!I?S'3-3L
MR[$^'#_A9/QH\>JI/C3XK?%#Q]KBH@+:UXU\=>,?$6IS855)_M/7=>U>_F;C
MFZNYW.?F-?Z-G[8__!J_^PQ^T=X_;XB_!?Q3XO\ V3M0U:_>\\5^$_A_I.E>
M)?AUJAGE$ES<:!X4UNXM&\&WCG(CM]#U-/#D08^5X>C;YJ_4#_@G[_P2-_8L
M_P""<&@)%\"_AVNL?$B[M([;Q)\;OB";3Q)\4=?(C19HXM8-I;67AG2Y73S/
M[#\)V&C:86.^XAN9]T[>Q+.\'"/M:.'?UB:2FG"$&W&W\2JDW)=K7;22?+T\
M:&1XV<U1K8FV%IN\6IRFFG_S[I-VA)[-NR73GZ_R*_\ !-G_ (-4_C/\8!HG
MQ0_;]U[4O@/\/9&LM1LO@MX5N=/O/C!XEM"RW+6WBK56CU#1/AW97,82">TB
M76?%)CFGC>#PY>PQ7!_N7_9E_9*_9R_8Y^'5E\*_V:_A+X2^%/@VT6%KFU\/
M6&-4UV]B@CMSJWBCQ#=O<Z]XGUJ:.)/M&JZ[J-_>RD<S!<*/HNBO Q6.Q.,E
M>M.\;WC3C[M.+\HW>O\ >DW+NSZ'"X'#8.-J%.TFK2J2]ZI+UE;1?W8J,?(*
M***Y#K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M K7M[::;9W>HW]S#9V%A;3WM[=W$BQ6]K:6L3SW-S/*Y"1PP0QO++(Q"HBLS
M$ &OAG_AZ-_P3=_Z/N_9,_\ #]_#7_YHJ^L/BO\ \DM^)7_8@>,?_4=U&O\
M$A('XD$],=!]>,_ECIC%>IEN7QQ_MN:K*E[+V=N6*ES<_/W<;6Y+WOU\CRLS
MS*67^PY:2J^V]K>\G'E]G[/M%WOS_*Q_LS?#?]OG]B+XQ>--%^'/PG_:U_9W
M^)/C_P 1O=1Z!X+\$?%WP/XF\3ZT]C8W6IWJZ9HFD:U=ZA>FTTZRO+^Y%O;O
MY-I:W%Q)MBB=E^MZ_P IO_@W0_Y3$?LA\Y_T_P"*WOT^"GQ%Z'TY^O(X]?\
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M]"T]%DE;Q%X,-Q*]U!9*)]=\.RZAI31W-VFD_9>["8*>+HXJ5.[J4%2E&/\
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M^$O%=W9VI=K:TNO$.@:?J\]M;M*6D:""6\>*)I"7*(I<ELUW=>,_LY?\F]?
MG_LC?PQ_]0K1*]FKA.U;+T04444#"BBB@ HHHH **** "BBB@ HKXQ_;2_X*
M _LI_L ?#P_$3]IOXIZ1X*M[R*Z'A;PE;!]8\?>.;ZU0,VF^#_"%AYNK:K+O
M>*.XOC%;Z/IOFI/JVI6%MNF7^(K]N'_@['_:E^+%YJGA/]BWP-HW[-O@0M=V
MUOX]\5VNF>/?C!JENWEK;7T-O>17'@;P;( )C+91Z;XMN%+Q-%K47EL'[,+@
M,5C'^YIMQ6]27NP5NG-U>NT4WY6./%8_"X-?OJB4VKJG'WJC7?E6R[.3C%V=
MG<_T,=5UG2-"LY-0US5=-T:PA!::^U6^M=.LXE )+27-W+#"@ !)+.  "3P*
M^7O%_P"WK^Q!X N&M/&W[7O[-/A:Z1VC>VUSXV_#G3[A)%.&C>&X\1)(D@/\
M#*&]J_R%_CA^UA^TS^TMK%UKOQ^^/GQ:^+VHW=R]TR^._'7B+Q!IMK+*2633
M-$O;^31=(M4!VQ66DZ?9V<,86*"&.,*J_/Q48)Z=Q[>WMT(YX'&.<U[$.'I6
M3JXI1?50I.2Z;2E.%[7?V>ESQ9\1QO\ N\+)QZ.=51?_ (#&$TO_  )G^RKX
M;_X*(?L%>,;I;+PM^V?^R]KUV^-MMIGQT^&US,2V-H$:>(RV6R,#&3D8'(KZ
MG\/>+/"WBZR74?"GB7P_XGT]P"E_X>UG3M:LW!Z%;K3;FYA8'L0]?X@([8_K
MGG\AQSSD<=<5ZE\+?C?\9_@AK4?B/X-?%KXD_"C7X95E35_ASXV\2^#-1WH0
MR^9=>'=3T^:1<JI,<K.AP RM@@5/AW3]WBKRT]V=%K[Y1F[6_P +["AQ&KKV
MF$:75PJW?RC*G%?^3?,_VS**_P TK]BW_@Z4_;[_ &?=2TO1?VB9-"_:X^&L
M;+#J$?B^&T\)?%2QM<Q(DNC_ ! \/Z>EG?RVT2R,\/BOPUKMSJ,C*LFL69+7
M!_M^_P"">O\ P5N_8T_X*2^'$G^!?CX:3\3+'3Q?>*O@?XZ^S:%\3_#:HL7V
MFX32OM$UIXFT6"29(_\ A(/"UYJVEAB([J6TN1);1^/BLNQ6$NZE.]-.WM87
ME#RN[)QOTYXQO?0]C"9EA,994JEJG_/JI[M3:[LKM2MUY'*Q^F]%%%<)WA11
M10 4444 %%%% !1110 4444 ?$.L?\%+O^">7A_5M4T#7?VW/V6M&US1-1O=
M(UG1]4^./P[L=3TK5=-N9;+4--U"RN=?CN;.^L;R&:UN[6XCCFM[B*2&5%D1
ME&=_P]%_X)N_]'W?LF?^'[^&O_S15_DO?MB@#]KG]J7/3_AH[XX'Z_\ %S/$
MQQ_3\^G6OG(]AG/)S_CG/)QT_+VKZ>GP_3G"$OK,USPC+^&G:Z3M?FZ/3ITZ
MNQ\M/B*I"<H_58/EE*-_:O6S:O\ !Y'^Q=_P]%_X)O?]'W?LF?\ A^_AK_\
M-%79>&O^"@?["OC*86_A7]L?]F+Q!.S!%ATOXX_#>[D9R0H14C\1EF<L0H4
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M <__ *@.F[DYY]NU?3<.[XS_ +EOSK?U_5U\OQ)_S!?]S/\ [@/VY_X-T/\
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MY5/[M?\ @S9_Y$W]NK_L9?@?_P"FOXB>G^>W:O[::_B7_P"#-K_D3OVZ^O\
MR,WP/Z_]@OXB=NPK^VBOG<T_W_$_XU_Z1$^CRK_D7X7_ *]_^W2"BBBN ] *
M*** "BBB@ HHHH X_P"(?_(@>./^Q/\ $W_IEO:_Q'+_ (OKW/>[N/7_ )[,
M>WL>F?Z5_MQ_$/\ Y$#QQ_V)_B;_ -,M[7^([?9^WWG_ %]W/O@^<X!],C(^
M@P.M?2\._%C/\-#[[U+?C_PS/F.)-L'ZU_RHG]HG_!L3_P %A?\ A#-;T?\
MX)P?M&^* GA'Q%>73_LP>-_$.I'R_#_B2\F2:?X,7=U=ML@T?Q!*]WJ/@0RR
MI%8ZV;KPQ#N76-#M+;^\ZO\ #NT_4=0T>_L=7TF^O-+U72[RUU'3-3TZYGL=
M0TZ_LIH[FSO["]M7BN;.\M+F.*XM;JWECE@G1)8F2158?Z@?_! /_@KI8_\
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M+N2RU70]<T>ZBO=/U"QN8R#'+;W$2M@[XY4+0RQR0NR-_K/?\$=_^"BFC?\
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M $P3_P#6/N.G0?2O]=K_ (+6?\HH_P!O#_LWSQ?_ .VE?Y$HQZYSV& .G?\
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M4BXR7KLUV<79Q?1I,_P[.XX.?SP.@P".Q_\ UDU_33_P:P?M<7_P+_X*%_\
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MN&79QAL'A84*E.O*<93;<(TW&TI.2MS5(N]GKIN?ZY-%?Y&W_#[_ /X*T?\
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M':ZL+G3M2O\ \_H99(94GAD>&>%TEAEB=XY(I4;>CQR(RM'(C@,CJP96&5/
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M$/U_S_*O[::^6S3_ '_$_P"-?^D1/J\J_P"1?A?^O?\ [=(****X#T HHHH
M**** "BBB@#C_B'_ ,B!XX_[$_Q-_P"F6]K_ !'+\9OKS_K[N1_Y&?///KGI
MZGM7^W'\0_\ D0/''_8G^)O_ $RWM?XCE_\ \?U[TQ]JN.O_ %VD&!_4^HZ]
MZ^EX<^+&?X:'YU/37MJM3YCB3;!^M?\ *B?K]_P0"2.7_@L#^Q)%+&LD<GCK
MQQ'(DB!XW1O@[\1E>-U8%71E8JRL"&7@@@XK[_\ ^#CS_@C\W[&/Q>G_ &M_
M@'X;-M^S!\;_ !&Z>(M T>TVZ?\ !GXJZIYUY<Z.D-O&(]/\%>-)8KG4O#+N
M!;:9K#:CX>\R&*30;:;X$_X-_P _\;A/V(<8Q_PG?C7//4_\*?\ B+V)S^F?
MPK_4W^.WP/\ AI^TG\(/B#\"_C!X;M?%GPW^)GAO4/"_BG1+H8\ZQOXBJW5E
M< &6QU73K@0ZAI.I6Y2ZT[4;:VO+9TFA1A>9XRI@\THU8ZQ>%IJK3Z3A[6K=
M/LU;FB^CM?1M$99@X8W*J]&5E+ZU.5*=KN$U1HV?FG\,EU3[I-?XG@.,>G?'
MOZGKP"/;D=#7]K7_  ;$?\%A?^$4U31O^";W[1WBG'AO7KV;_AEGQAK,TCKH
MFNW;/<WWP;U"^<F.VTG5Y1/J?@-KHI':ZQ-?^&UN2NHZ!8P?S@?\%1O^"='Q
M,_X)H?M2^)_@9XT34-:\#ZD;GQ/\%_B--:^39_$+X=W-V\=A>&6%?LB>(M#=
MET;Q9IT7EM9:O#]I6WBTW4M,DF_/+3-3U+1=1T_6='O[W2M7TB^M=3TK5-.N
M9[*_TW4;":.[LM1L;RW>.XM+VTNHXKFUNH'CFMYXTFC=)%5AZV(H4<RPF]XU
M$IT:BWC/HTM]'S1G%M75XZ.W+Y&'KU\KQC<HM2IRY*U)[3AHVK^:M*$N_*]5
M=/\ W#Z_B2_X.>/^"PG]BV6M?\$V_P!G'Q0!K&J6]L?VIO&F@ZC(LNE:5<(+
MFT^"UE=6<J;;S5X'MM0\?KYA$>D2VGAF:-SJ>L16W'>#?^#IMM+_ ."6E_8:
MTD]]_P %&= AM/@_H-Q>:;)<^'O$4,NEJEM^T1JDZ0+IPDT[3(YAJWAIV2XU
M'QY#;&.VC\/:D]U;?Q-^)O$NO^,?$.N>+O%6L:CXB\3^)M6U'7_$.O:O=2WV
MJ:SK6KWDU]J>J:E>W#23W=]?7L\US<W$KL\LTCR,26->'EF4U%B)5,5#EC0F
MXPC+:I5C;WEI[U.-TUTE*RUM*+]W-<VA]7C2PD[RQ$%*4UHZ=*7V>\:DMFMX
MQN]&XLQ.O_ CS@>G)XR3W]O?M7])W_!N_P#\$@;C]O'XXQ_M%?&_PW<M^R?\
M"/$-A=36UZHALOC#\3],EMM4TOP'%$X+ZAX6T0"UU7QY(JK9W<$NG^&O,N/[
M3U1++\H_^"</[ GQ7_X*._M0>"OV>OAI#=Z=I5Y,FM?$WX@_89+O1_AK\/;%
MPVM>)-49=L)O)DVZ7X<TV66-]8UZZLK-62W-U<6_^MO^S3^SG\*?V3/@=\.O
MV>_@KX<MO#'PZ^&GAZTT'1;&%$^U7LL8\W4]>UFZ55DU+Q!X@U&2ZUC7-4N"
MUQJ&IWES<RL2X [<YS#ZO#ZM1E^]J+WVO^74';YJ<E9*^JBI2T;C?AR7+OK%
M3ZU6C^YI2]R+6E6HM=5UA#=])2M'5*:/\QC_ (.-H(+3_@L!^U/;6T,5O;6T
M/P?M[>"%$BA@@A^"OP_CBAABC4)%'%&%2-$ 5%555<+Q^'P/KCL1T]_;MD@C
M'TYK]Q_^#CW/_#X?]J['7_BT?'_=&/ .20>/;MU-?AMTSG/_ .KCWSCV/':O
M1R_7 X71?P*7KM':_?7K:^UM;^=F/^_XO_K_ %/S/]KC]G+_ )-Z^!/_ &1O
MX8_^H5HE>S5XS^SE_P F]? G_LC?PQ_]0K1*]FK\_/T);+T7Y!1110,****
M"BBB@ HHHH _R6_^"]GAV\\,_P#!7;]MZQO(I(S?_$[2/$5LTBLHFM/$_@#P
M?X@MY8B<!XA'J7E!DW*'C="=ZL!^47AC55T'Q'X?UR16D71]<TG5&C4 LZZ=
M?P791<\;G$!5>V2,Y%?U2?\ !VU^S+JOPZ_;=^&7[2ME8.OA#]H?X566A7NH
M0VT@AC^(7PGF71]5@N[D+Y*SWGA'5_!\UG$[+-/%8WS(&2U?;_)\,<C@>YYY
M^O;W-??9=*-;+\/;;V4*4DK[P2IRWZ^Z^G:VCU_/LPA*AF&([JNZL;]IOVL7
MV:]Y?D]3_;Q\ >(-/\6>!/!7BG29X[K2_$GA+PYKVFW,3!XKBPUC1[/4+2:-
MQPR26]Q&ZL.H(-=;7\^/_!MQ^W7HW[6W_!/;P+\,-;\0VM[\9_V4[.Q^$'C;
M2)9L:K-X*TX3Q_"CQ28)I9+FXL;[PA;6WA^XU+F.;7O#>KJ?+;:E?T'5\+6I
M2H5:E&:M*G.4'I;9[^C6J[IH^\H58UZ-.M!WC4A&:\KK5/SB[Q:Z--,****S
M-0HHHH *,T5^<_\ P58_;>\,?L ?L0?&?X]:O>P)XN'A^[\%_"/17E5+KQ%\
M5?%UK<:7X2M+:+<)9;;2KF23Q)K4D2NUIH.BZE=;28E5JA"52<803E.<E&,5
MNY2=DEZMDSG&G"4YM1A"+E*3V48J[;]$C_+F_P""G_CW3OB?_P %%OVW/'.D
M2Q3Z3KO[3OQD_LR>'_53Z?IGC;5])L[B-@Q61+BWL(YA*"5EW^:N X \,_96
MT.Y\3?M._LX>'+)3)=^(/CS\(-#MD7[SW.K?$+P]80(O?<TMP@'N1P<5X?>7
MMUJ%U=7]]<37=[>W,UW=W4\CRSW-U<RM-<7$\K'?)-/*[RR2.S.[LQ8[B37[
M;?\ !O%^R[<_M.?\%2O@ ;K3A?\ @[X$7M]^T#XREF@>6VMU^'2QW'@Q2^UH
M8[F7XBWOA%[=9&!>*WNGC!:$E?OZS6&P,U)VC1P_)WNX4U%+;J^6*WU?7<_/
MJ/-B\?!I6E7Q7._[JE4YY/?:*NWKLM#_ %6XU\N-$Z[$5,^NT 9_2GT45^?'
MZ&%%%% !1110 4444 %%%% '^+?^V+_R=U^U-Z_\-&_'#C&?^:F>)P!CZ9/]
M,8SW?_!.CC_@H'^PUU_Y.^_9MR/^ZQ^#O_K5PG[8O_)W/[4V1Q_PT=\</7G_
M (N=XGSSV'^>IKO?^"='_*0+]AOI_P G??LV8QQG_B\7@W/U_'GKP*_0Y7^H
MO37ZJ^G3V6FRVZ[[]]4?G,/]]C_V%1_].H_V4Z***_/#]&"BBB@#P3]JKQ3I
MW@C]F#]HSQEK$T=OI7A7X%?%KQ#J,TKK'''9Z1X"UZ_N&=W(51Y<#<L0!WK_
M !7B,8'08!SW_F>Y[=S^-?ZF?_!R%^U3IG[-G_!+SXR>&X]0MH/&O[29M/@%
MX2TV27;<WVG>+ ]Q\0;F*)3YC06/@*QUV*:7;Y*7-_8PRD&YC5_\LL'MC'KC
M'8'U]NHYR,^^?J^'H2C1Q%5I\LYPBK[/V:;;7?\ B6O9I/YV^2XCJJ5;#4EO
M3A4G+R]HXI)]M*=]^NRZ_OG_ ,&S?AVZUW_@KY\ +RW!*^&/"OQC\17A"@@6
MH^&/B/1<L>-H\_6K< C(R54#YLU_J55_GB?\&A'P&U?Q7^V5\??VAYK>1?"_
MP@^!A\"0W3P2>3/XO^*_BC2+FQBM[@KY32V7ASP+XB-W&CF2)-0LV=-LZ-7^
MAW7F9Y)2Q\HII^SITH.W1\O-:_6W,O\ A[GJY%"4<O@VK<]2I->:NHW^^+MY
M:]0HHHKQSV HHHH **** "BBB@#\N_\ @M;_ ,HHOV\/^S>_&'\K2O\ (E)[
M=0,X_P CW&0#^M?Z[7_!:S_E%'^WA_V;WXO_ /;2O\B;.,#((Z$=0.<Y^O\
M]?TKZSAW^!B':[]M'_TA7>S>G]=+_)<1_P ?#?\ 7J?_ *6?>_\ P3Q_X)V?
M''_@I?\ &CQ%\#?@)K7P^T/Q;X9^'NJ_$O4;OXD:UK.A:(^@:1KWASP[/;VU
MSHGA[Q)=R:D]]XFL'B@DLHH&MHKJ1[E)$CBE_9W_ (A'_P#@I6?^:B_LH?4?
M$/XA#GI_T2GVK6_X-$O^4C7Q@YS_ ,8D>-^QX_XNE\(>.>WIZ?S_ -'.L<RS
M/&87%RI4IQC",*;2<(MW<4W=M7W_  5M3;*\KP>*P<*U:$I5)2J)M5)Q5HS:
M6B:6R/\ -U_XA'O^"E?/_%QOV4,'M_PL/XA8_P#54TO_ !"/_P#!2OJ/B+^R
M@/\ NHGQ"_7_ (M0/<?0^U?Z1-%>?_;>8?\ /V';^%3\O+R1Z']AY=_SZG_X
M-J?_ "1_G@?!C_@U0_X*,_#KXQ?"?X@ZSX__ &6[G1_ OQ+\"^,M6MM.\?\
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M=1Z<D\@]?KS^&.AR*_VVOA%_R2?X8?\ 9//!7_J-Z;7^))GW([]..1SD>_\
M+MBO]MOX1?\ ))_AA_V3SP5_ZC>FUT\1W_V._P#U$?E0^_S=]7KH<G#>^,]*
M'YUCT.BBBOF3ZD^/?VXOV'/@)_P4"^ WB3X"?'WPS#JNC:G#<7?A7Q3:0VZ^
M+/ASXM%K-;Z9XS\&ZE-'(UAK&G-+^\A8/8:M9F?2]5MKK3[F:!O\KW_@I9_P
M32^/?_!,KX[WWPH^+6GRZSX,UR6_U#X1?%O3K.6+PO\ $SPM;3JB7EH?,N$T
MKQ%IR36\/B7PO<W#WNCW<B,C7FF7>G:C>?[ E?)_[9_[%WP&_;S^!7B?X ?M
M!>%8O$'A778_M.D:Q:B*W\4>"/$ENC_V7XM\'ZNT4DNE:WILK9#*'M;^U:?3
M=3M[S3KNYMI?2R[,:F"J6=YT)->TI_->]"^TE;5;26CMHUYN8Y;3QU.^D*\$
M_9U._P#<G;>+[ZN#UCU4O\9$'K^.<>F/8=,XS@]O?E?0'\"?3&.Q/?D=CV(%
M?I;_ ,%.O^"8'QZ_X)B?'*[^&_Q.L9O$/P[\137E[\(OC'I=C=1^%?B!X>21
MC'$TSIY.D^,-)A,4?B;PQ-+)<6,Y%W9R7NDW-G?S_FF>3P1T]AC)Y]_K^/KB
MOMZ5:G6IQJTI*5.:NI+Y*UM;-/1IZIW32:/A:M*I0J2I58N$X.THO\T]FFM4
MUHUJC^[3_@S:_P"1._;K_P"QE^!__IK^(G&>^.F:_MHK^)?_ (,VO^1._;L_
M[&;X'_A_Q*_B'Q^'_P!?O7]M%?"YI_O^)_QK_P!(B?>95_R+\+_U[_\ ;I!1
M117 >@%%%% !1110 4444 <?\0_^1 \<?]B?XF_],M[7^([?G_3KLYQB[N/7
M!_?R>GTY[_6O]N+XA_\ (@>./^Q/\3?^F6]K_$<OQ_IUYV_TNY!)[?O7/'U!
M/'OCKDU]+PZKRQ?I1_.KTL[L^8XDVP?K7_*B?L#_ ,&_YS_P6%_8A]?^$\\:
MY_\ #/\ Q%_+\\?C7^LE7^3;_P &_I_XW"?L1>_CSQM_ZJ#XB_YZ=/;K_K)5
MS\0_[[37;#0[O_E[6.GA[_<JO_85/_TU0/RW_P""MO\ P3/^'W_!3C]EK7OA
M3JZ:;H/Q=\)K=^*?@5\2+BT$EUX1\;0VYQIE]/'MN9/"7BV*--&\3V"NR>2]
MKJT$1U+2-/DC_P FSXL_"CX@_ WXE>-_@_\ %7PQJ7@SXB?#KQ)J7A3Q?X:U
M:$PWNDZQI<YAGA<'Y)K:5=EW87L#RVFHV,]M?6<T]K<PS/\ [;=?R;_\'*G_
M  1Z/[4'PVOOVX_V>/"[W/[0?PB\.@?%;PQHT$DE[\6/A3H4%S.VHV.G6Z,U
M_P".? L#R75L8E-[KOAB*ZTG;=WFFZ';K.3YB\-4^KU9?N*LE9O:E4;7O>49
M6M+L[2Z.]9SEWUJG]8HQ_P!HI+5):U::UY?\<-7'JU>.ONV_SJAR/J> .>>3
MCVX(R?S[UV'P_P# /C#XJ>.?"/PT^'GA_4?%GCOQWXCTGPGX2\-Z5 T^HZUX
M@UR^AT_3-.M8P0-]S=SHADD9((49I[B6*&.21>0&<9'OU';'X_USP"> *_T"
M/^#93_@CVWP;\(Z9_P %"_VC/"K6_P 5?'^CS)^SSX-U^P*7GP^\ :O"8[CX
MC7EG=IOL_%7CJR<Q:"6C6YTCPA,\ZR1S^([FWM?I,?C(8*A*J]92]VG3OK*I
M9:.Z^&*UFUTNKW:1\SE^"GCL1&DKJ$?>JS_E@GK;^]+:*[Z[1;7[+_\ !&;_
M ()<^#O^"8O[+>D^$+RUTK5OVA?B7:Z3XI_:!\<V>+K[9XG%H6M?!.AZ@\,,
MK>#O PNKG3=(58K=-2O9-3U^>WCNM5D1/U]HHKX.I4G5J3J5&Y3G)RDWU;_)
M+9):)62/OZ=.%&G"E3BHPA%1C%=$OS;W;W;NWJS_ "JO^#CXX_X+#_M7_3X1
M_P#JF? /Y?I]>,5^&YYZ9QVZ\8ZG@\]>OX5^Y'_!Q[_RF(_:MR,\?"3MW_X4
MQX Q_G_$U^&Y//<'DGWSR1SP./8Y],U]]E_^XX337V%/?RC'Y]%KJEMZ?G^8
M_P"_XO\ Z_U/S/\ :W_9R_Y-Z^!/_9&_AC_ZA6B5[-7C/[.7_)O7P)_[(W\,
M?_4*T2O9J_/C]"6R]%^04444#"BBB@ HHHH **** /R4_P""U/\ P3XB_P""
MC'[#7C_X5:!:V[?&/P*__"T?@;?2K$KGQ]X;L[HGPRUQ*5%O9^.-'EU#PM<3
M%@EM/J%EJ#JYL44_Y,.NZ'K/AC6]8\-^(M+OM$\0>']5U'0]<T75+6:RU/1]
M8TF\FL-4TO4;.=$GM+[3[Z"XM+RTGC66WGBDBD4.A _W":_C)_X.(O\ @A!K
M'QDO?%'[>7[&?A!M2^):VEQJ_P"T'\&_#]I/+JGQ"2T@@1OB/X#TNU2077C"
MULX'/BSP];1+/XF@B76--277H[RVUGW<ES".'F\/6=J565X2;TA4=D^:[5HS
MM%-[)K56DVO!SK+I8F"Q-&/-6I1Y9P2UJ4T[KE76<&VTMY1;2NU%/^0__@F_
M_P %!?B__P $VOVF?#'Q_P#A9,^J:8HC\/\ Q/\ AW=7<EKH?Q+^'UW=P3ZO
MX<U%@LJ6FH1>0FH>'-=%O-<:'K,$%RL=Q92:A8WO^J_^P_\ MW?LZ?\ !03X
M*Z-\:_V>/&EEK^FW$5K;>+?"5U-!!XU^''B62W2:[\*^-M"65[G2M3M69OLU
MP5?3=8M!'J6CW=[83Q3M_C7SP3VEQ/:WD$UM=VLTMO<VUQ%)#<6]Q YCF@GA
ME"R1312(\<D4B*T;JR.%(VU]%?LO_M=_M&?L9?$O3_BW^S5\5/$WPM\96;PK
M=SZ-<K-HOB*PBDWG1_%?AN^2YT'Q/H\F6#Z=K.GWD,3.TUJ+>Z2.=/8S+*XX
MVU2FU"NHI*3TIU%964FE>Z7PR2;2T::2MXV69K/ _N:L93P[DW9?'2D]W"[2
M:>\H.VNJ:=^;_:-HK^)']CG_ (.^?"]SIVG>&?VY_P!G[6-+UB)+:VG^*?P"
M>VU31]0<_+/?:Q\./%&IZ??Z,% \R3^P_%&O^:Q80:9 H5#^XGPY_P"#AO\
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MS=YU).<GYMWLO);)=$K'WM*G&C2ITH*T*<(PCZ15M>[>[?5ZA11169H%%%%
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MQ<W-S/(L4%O;P17[RS3S2LL<44:-))(RHBEB!2U[?U_307_K^O5?>=Q1110
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M!>!?!G@6SNY[^T\%^%/#OA.UOKE(X[F]M_#ND6>D07=Q'%^Z2>XCLUFE2/\
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MO#L5C-KNDZ=J;0FXN]*CU*&XL#>JD16$W=O/ C-O>&4+L/\ ,E_Q!X?L<?\
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B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V #8# 2(  A$! Q$!_\0
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EVX HHH ],\":OJ6KZ/<-J:VRR6]PT$?D%L%% P3GO1113$?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
